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Abstract 
 
Swine barn air is a heterogeneous mixture of dust, bacteria and irritant chemicals 
including ammonia and hydrogen sulphide.  Gram-negative bacteria are commonly found 
in swine barn air and significantly contribute to pulmonary disease in unprotected swine 
barn workers, through the endotoxin moiety, lipopolysaccharide (LPS).  Toll-like 
Receptor-4 is the ligand for LPS.  It is found on many cell types including monocytes, 
macrophages, neutrophils, endothelial cells, and to a lesser extent, epithelial cells.  The 
severity and outcome of acute lung injury following barn air exposures depends upon the 
balance between epithelial and vascular endothelial repair mechanisms, including 
angiogenesis.   Vascular Endothelial Growth Factor (VEGF) is an endothelial mitogen 
produced by mesenchymal and alveolar Type II epithelial cells and by activated bronchial 
airway epithelial cells.  Research investigating the role of cytokines in angiogenesis has 
shown that close proximity of immune cells and endothelial cells modulates the 
production of various compounds that regulate vascular function.  Given that LPS is the 
ligand for TLR4 there appeared to be a role for TLR4 in angiogenesis, particularly 
following endotoxin exposure. To determine whether this was occurring, we examined 
whether exposure to swine barn air alters vascular density in the lungs and the role of 
TLR4 using a murine model.  Toll-like Receptor-4 wild-type (C3HeB/FeJ) and TLR4 
mutant (C3H/HeJ) mice were obtained and exposed to swine barn air for 1-, 5-, or 20-
days for 8 hours/day.  Wild-type animals showed a 127% increase in vascular density 
after 20-days barn air exposure.  Vascular Endothelial Growth Factor-A protein levels 
were decreased by 0.62-fold after one-day swine barn air exposure in wild-type animals, 
indicating that VEGF-A is being used as a pro-angiogenic mitogen.  Transcription of 
VEGF-A mRNA was increased in wild-type animals after all swine barn air exposure 
periods.  The receptor VEGFR-1 showed increased mRNA transcription over all time 
points.  These effects were only observed in TLR4 wild-type animals, indicating that 
these effects are mediated by TLR4.  Further, VEGF-A and VEGFR-1 appear to be 
involved in the manifestation of TLR4-induced angiogenesis in the lung 
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1.0 INTRODUCTION 
1.1 Swine Barn Air, Inflammation and Pulmonary Disease 
 
Swine barn air is a heterogeneous mixture of dust, bacteria and irritant chemicals 
including ammonia and hydrogen sulphide (Zhang, 1998).  These bioaerosols in the barn 
air are a risk factor for the development of chronic respiratory symptoms and lung 
dysfunction (Zejda et al., 1993; Zejda et al., 1994). Gram-negative bacteria are 
commonly found in swine barn air and significantly contribute to pulmonary disease in 
unprotected swine barn workers. Single, 3-5 hour exposure of naïve, healthy, non-
smoking subjects to swine barn air increases interleukin (IL)-6 in serum and IL-6 and IL-
8 in nasal lavage and inflammatory cells in bronchoalveolar lavage fluid (BALF) 
(Larsson et al., 1994; Dosman et al., 2000).  These changes are characteristic of an 
inflammatory/immune response.  Following exposure to an antigen, antigen presenting 
cells (eg. macrophages) will present the antigens to B-cells.  Antigen presentation 
combined with cytokine expression secreted by helper T-cells (Th1 and Th2 cells) 
enables B-cell maturation and activation, with many feedback cycles to other 
lymphocytes, and initiation of the inflammatory process.  Thus, biologically speaking, the 
changes to inflammatory cytokines after barn air exposures mean that a single exposure 
to the barn air initiates acute pulmonary inflammation and compromised functional 
capacity of the lung (Cochran et al., 2002; Singh and Schwartz, 2005).   
 
Research into pulmonary inflammation following barn air exposures has focused upon 
endotoxin, the lipopolysaccharide (LPS)-containing component of the Gram-negative 
bacteria cell wall.  Lipopolysaccharide is the principal pro-inflammatory component of 
  2
the Gram-negative bacterial cell wall.  Unrefined LPS is called endotoxin but for the 
purposes of this report endotoxin and LPS are considered synonymous.  Bacterial LPS 
can be volatilized if sloughed from the cell wall.  If inhaled, bacterial LPS can induce 
inflammation through the Toll-like receptor subfamily in many organs, including the 
lungs (Faure et al., 2000; Koay et al., 2002; Fan et al., 2003; Heumann et al., 2003; 
Finberg et al., 2004; Gon et al., 2004; Kobayashi and Flavell, 2004; Lin et al., 2004; 
Moreno et al., 2004; Muir et al., 2004; Ushio et al., 2004).   
 
1.2 Toll-Like Receptor-4 (TLR4)  
Toll-like receptors (TLRs) are mammalian homologues of the Toll receptors identified in 
Drosophila.  To date 11 mammalian TLRs have been identified.  All have a highly 
conserved genetic sequence [18-21], and recognize pathogen-associated molecular 
patterns (PAMPs) to initiate the immune response.  Toll-like Receptor-4 and TLR2 
recognize conserved molecular patterns associated with a wide range of microbial 
pathogens.  When activated, they initiate transcription of proinflammatory cytokines such 
as interleukin (IL)-1β, TNF-α, IL-6 and IL-8 (Charavaryamath et al., 2005).  Mammalian 
TLR4 regulates the innate immune response and is the most critical sensor for the 
recognition of and signaling events associated with LPS.  Toll-like Receptor-2 recognizes 
lipoteichoic acid from Gram-positive bacteria to generate inflammatory responses.  
Lipopolysaccharide can also influence expression of TLR2 in human leukocytes and 
mouse lungs (Dziarski et al., 2001).  Therefore it is essential to understand the expression 
of these proteins for a better comprehension of the host response to pathogens. 
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Toll-like Receptor-4 is the ligand for the endotoxin moiety (Faure et al., 2000; Koay et 
al., 2002; Fan et al., 2003; Heumann et al., 2003; Finberg et al., 2004; Gon et al., 2004; 
Kobayashi and Flavell, 2004; Lin et al., 2004; Moreno et al., 2004; Muir et al., 2004; 
Ushio et al., 2004).  It is found on many cell types including monocytes, macrophages, 
neutrophils, mast cells, B-cells, endothelial cells, and to a lesser extent, epithelial cells 
(Faure et al., 2000; Koay et al., 2002; Gon et al., 2004; Muir et al., 2004; Ushio et al., 
2004).  The molecular mechanism by which TLR4 initiates the inflammatory response is 
well characterized, and is represented in Figure 1-1 and Figure 1-2.   The initial step of 
these mechanisms differ between cell-types because of the presence or lack of 
membrane-bound CD14, a glycoprotein required for binding of LPS to TLR4 (Heumann 
et al., 2003; Finberg et al., 2004; Lin et al., 2004; Moreno et al., 2004).   
 
  4
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-1:  Cellular cascade initiated by ligation of LPS to TLR4 in macrophages. 
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activated kinase (TAK), TAK1-binding protein (TAB), NIK, IκB kinase (IKK), Nuclear 
Factor- kappa B (NF-κB).  
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Figure 1-2:   Cellular cascade initiated by ligation of LPS to TLR4 in endothelial 
cells. 
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Toll-like Receptor-4 activation by LPS induces multimerization of TLR4/CD14/MD-2 
and recruitment of MyD88 or IRAK proteins.  The proximity of IL-1 receptor–associated 
kinases (IRAKs) causes a conformational change via auto- or cross-phosphorylation 
resulting in reduced affinity for the TLR signalling complex.  The IRAKs released by 
activation of the TLR4 complex activate downstream molecules such as tumor necrosis 
factor (TNF) receptor-associated factor (TRAF)-6, ultimately causing NF-κB 
transcription.  The presence of NF-κB initiates transcription of pro-inflammatory 
molecules including tumor necrosis factor-alpha (TNF-α), IFN-β, granulocyte-
macrophage colony stimulating factor (GM-CSF), granulocyte colony stimulating factor 
(G-CSF), induced nitric oxide synthase (iNOS), and IL-6 (Suzuki, 1999; Miggin and 
O'Neill, 2006). 
 
Negative feedback of the TLR4 signalling cascade is mediated, in part, by IRAK-M, 
which is recruited to the signalling complex together with IRAK-1 and IRAK-4 (not 
shown).  This association inhibits the release of IRAK-1/IRAK-4 from the TLR 
signalling complex by inhibiting the phosphorylation of IRAK-1/IRAK-4 or stabilizing 
the TLR-MyD88-IRAK-1/IRAK-4 complex.  Both these mechanisms result in the 
interruption of downstream signalling (Kobayashi and Flavell, 2004; Tsan and Gao, 
2004).  Other suppressor molecules include SHIP, Suppressor of cytokine signalling 
(SOCS)-1 and Toll-interacting protein (Tollip) which directly inhibit TLR4 signalling 
through interactions with IRAK-1 (Kobayashi and Flavell, 2004; Yoshimura et al., 2004), 
and A20 which has inhibitory effects on NF-kB (Gon et al., 2004).   
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1.3 Lipopolysaccharide Binding Protein (LBP) 
Lipopolysaccharide binding protein (LBP) is critical to the LPS response (Brass et al., 
2004).  It is a 60 kDa serum glycoprotein present at low levels in the lung (Martin, 2000).  
Lipopolysaccharide binding protein binds the lipid A component of LPS to form a high-
affinity LBP/LPS complex that potentiates the cellular response to LPS by transferring 
LPS to CD14 (Brass et al., 2004).   
 
Following LPS exposures, LBP protein and LBP mRNA are increased in the lung.  
Animals expressing LBP were demonstrated to have enhanced LPS inflammatory 
response in the lower respiratory tract, and a more severe fibrotic response in 
subepithelial mucosa following endotoxin exposures (Brass et al., 2004). 
 
1.4 CD14 
CD14 is part of a multimeric receptor complex for LPS.  CD14 can be membrane-bound 
or found within the serum as a soluble protein [16].   Monocytes, macrophages and 
neutrophils express membrane-bound CD14 (Gangloff and Gay, 2004; Lin et al., 2004; 
Moreno et al., 2004).  Stimulation of endothelial and epithelial cells by LPS appears to be 
soluble CD14-dependent (Pugin et al., 1993; Backhed et al., 2002; Lin et al., 2004).  
CD14 has no intracellular domain, thus a physical association between CD14 and 
TLR4/MD-2 is required (Finberg et al., 2004; Fitzgerald et al., 2004; Gangloff and Gay, 
2004; Lin et al., 2004; Moreno et al., 2004) to induce the inflammatory response.    
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1.5 Endotoxin Tolerance 
The phenomenon of endotoxin tolerance has been widely observed in the literature 
(Nomura et al., 2000; Qu et al., 2003; Fan and Cook, 2004; Lin et al., 2004; Moreno et 
al., 2004; Sly et al., 2004; Charavaryamath et al., 2005).  As the name implies, prolonged 
exposure to LPS has been demonstrated to result in a reduced cellular response, or the 
development of tolerance.  There are several theories surrounding this process, including: 
1) Reduced expression of membrane TLR4 (Nomura et al., 2000); 
2) Altered TLR4 signaling cascade (Fan and Cook, 2004); 
3) Depletion of soluble CD14 (endothelial and epithelial response) (Lin et al., 2004; 
Moreno et al., 2004); 
4) Depletion of LBP (Brass et al., 2004); 
5) Increased SHIP expression.  SHIP-mediated LPS tolerance is associated with 
inhibition of both NF-kB and STAT-1 activation: two of the principal endpoints 
of LPS signal transduction (Qu et al., 2003; Sly et al., 2004); 
6) Potential cytokine interactions (Qu et al., 2003; Moreno et al., 2004; Peck et al., 
2004). 
 
 
Observation of endotoxin tolerance is anticipated for this model.   Determination of the 
mechanism by which tolerance occurs is, however, outside the scope of this research.  
 
1.6 Angiogenesis 
Angiogenesis is the process whereby new blood vessels are differentiated from existing 
vascular endothelial cells.  Several factors have contributed to our interest in 
angiogenesis with respect to pulmonary inflammation.  First, the severity and outcome of 
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acute lung injury depends upon the balance between epithelial and vascular endothelial 
repair mechanisms (Mura et al., 2004).   Since endothelial repair can include 
angiogenesis, this process will be of interest with respect to the inflammatory process 
following LPS exposure.  Second, an increase in vascular density within the lung will 
allow for increased leukocyte infiltration following pulmonary insult, thus, potentially 
exacerbating pulmonary inflammation following LPS exposure.   
 
There are many factors known to promote angiogenesis, as reviewed by (Papetti and 
Herman, 2002) (Table 1-1 and Table 1-2).  Of these, this project will focus on the 
Vascular Endothelial Growth Factor (VEGF) family and its receptors.   
 
Table 1-1: Important Pro-Angiogenic Growth Factors 
 
Factor Function 
VEGF family • Increases endothelial cell permeability 
• Stimulates endothelial cell proliferation 
• Inhibits endothelial cell apoptosis 
• Enhances endothelial cell migration 
• Stimulates in vivo angiogenesis 
TGF-$ • Supports anchorage-independent growth of fibroblasts 
• Stimulates/inhibits formation of endothelial cell tubes in vitro 
• Inhibits production of other proteases/stimulates production of 
protease inhibitors 
• Stimulates VSMA production by pericytes 
• Chemotactic for monocytes and fibroblasts 
• Stimulates in vivo angiogenesis in presence of inflammatory response 
• Increases vessel wall stability 
Angiogenin • Stimulates angiogenesis in vivo 
• Supports endothelial cell binding and spreading 
Angiotropin • Stimulates random capillary endothelial cell migration 
• Stimulates endothelial cell tube formation 
• Stimulates in vivo angiogenesis 
"v$3 integrin • Highly expressed on activated endothelial cells 
• Mediates endothelial cell attachment, spreading and migration 
• Present on angiogenic capillary sprouts 
• Required for bFGF-stimulated angiogenesis in vivo 
• Suppresses endothelial cell apoptosis 
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Table 1-2:  Other Pro-Angiogenic Growth Factors* 
 
Factor   
Ang1 
Ang2 
aFGF, bFGF 
PDGF 
TNF-α 
EGF, TGF-α 
G-CSF, GM-CSF 
Prostaglandin 
Nicotinamide 
Monobutyrin 
αvβ5 integrin 
αvβ1 integrin 
VE-cadherin 
Eph-4B/Ephrin-B2 
Ephrin-A1 
Eph-2A 
*from (Papetti and Herman, 2002) 
 
 
1.7 Vascular Endothelial Growth Factor (VEGF) 
The human VEGF gene family includes five isoforms: VEGF-A, VEGF-B, VEGF-C, 
VEGF-D and VEGF-E.  These isoforms arise from alternate exon splicing (Mura et al., 
2004).  Vascular Endothelial Growth Factor mRNA is most abundant in the lung, kidney 
and spleen, where transcription is localized primarily in epithelial cells and vascular 
smooth muscle cells (Shifren et al., 1994; Corne et al., 2000; Voelkel et al., 2006).  The 
major source of VEGF in both animal and human lungs are mesenchymal and alveolar 
Type II epithelial cells (Kaner and Crystal, 2001), though  activated bronchial airway 
epithelial cells also release VEGF (Lee et al., 2000).  Further evaluations using RT-PCR 
have demonstrated that VEGF is produced from various sources (Wellmann et al., 2001) 
including human peripheral blood leukocytes, which contain lymphocytes, monocytes, 
and other cells (Gunsilius et al., 2000; Harter et al., 2004; Mor et al., 2004; Conejo-
Garcia et al., 2005).  Vascular Endothelial Growth Factor released by alveolar epithelial 
cells may modulate the adjacent vascular endothelium in a paracrine fashion (Shifren et 
al., 1994), thus playing a role in localized angiogenesis following epithelial damage. 
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1.7.1 Vascular Endothelial Growth Factor Isoforms 
The most studied VEGF isoform is VEGF-A (often denoted VEGF in the literature).  
Vascular Endothelial Growth Factor-A is a relatively specific mitogen for vascular 
endothelial cells.  It elicits a pronounced angiogenic response in many in vivo and in vitro 
models.  Studies have demonstrated that VEGF-A stimulates endothelial cells to degrade 
the extracellular matrix (ie. via matrix metalloproteinases), to migrate, and to form 
capillary tubes (Veikkola and Alitalo, 1999; Voelkel et al., 2006).  Degradation of the 
extracellular matrix, and hence regulation of vascular permeability, is important to the 
initiation of angiogenesis (Dvorak et al., 1995; Cebe-Suarez et al., 2006; Voelkel et al., 
2006).  Following matrix degradation endothelial cells may migrate, thus allowing the 
formation of new capillary tubes 
 
Studies have also demonstrated that endothelial cell survival in the newly formed blood 
vessels is VEGF-A dependent.  This is likely due to VEGF-A induced expression of anti-
apoptotic proteins in endothelial cells (Alon et al., 1995; Benjamin and Keshet, 1997; 
Gerber et al., 1998).   
 
The other isoforms of VEGF have similar roles to VEGF-A.  Vascular Endothelial 
Growth Factor-B is involved in the regulation of extracellular matrix degradation, cell 
adhesion and migration (Veikkola and Alitalo, 1999);  Vascular Endothelial Growth 
Factor-C stimulates migration and mitogenesis of cultured endothelial cells (Joukov et 
al., 1997); and  Vascular Endothelial Growth Factor-D acts as a mitogen for 
microvascular endothelial cells (Achen et al., 1998).   
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1.7.2 Vascular Endothelial Growth Factor Receptors (VEGFRs) 
There are three VEGF receptors (VEGFRs) (Veikkola and Alitalo, 1999).   Vascular 
Endothelial Growth Factor Receptors are expressed on many cell types, and VEGF 
affinity differs depending on the isoform.  The mechanism(s) by which VEGF-receptor 
interactions evoke endothelial cell function is not well understood; though it is known 
that initiation by receptor dimerization and subsequent autophosphorylation (Davis-
Smyth et al., 1996; Barleon et al., 1997) results in a functional signaling unit (Mura et al., 
2004).   Each consists of four regions: the extracellular ligand-binding domain, 
transmembrane domain, tyrosine kinase domain and a downstream carboxy terminal 
(Shibuya, 2006).  The extracellular domains of the VEGFRs contain seven 
immunoglobulin-like domains (Shibuya, 2006; Shibuya and Claesson-Welsh, 2006).   
 
Both VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1) are expressed on vascular endothelial 
cells and act by tyrosine kinase-dependent pathways (Olsson et al., 2006; Shibuya, 2006; 
Shibuya and Claesson-Welsh, 2006).  Vascular Endothelial Growth Factor Receptor-1 is 
also expressed on activated macrophages and monocytes, and promotes tumour growth, 
metastasis and inflammation (Mura et al., 2004; Shibuya, 2006; Shibuya and Claesson-
Welsh, 2006).  The specific roles of VEGFR-1 are still being elucidated, however, it has 
been suggested that VEGFR-1 is involved in vascular organization and the migration of 
macrophages toward VEGF-A (Fong et al., 1999; Olsson et al., 2006; Shibuya, 2006; 
Shibuya and Claesson-Welsh, 2006).  Conversely, VEGFR-2 plays no role in vascular 
organization, but has been suggested to mediate endothelial differentiation and 
proliferation (Fong et al., 1995; Mura et al., 2004; Olsson et al., 2006; Shibuya, 2006; 
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Shibuya and Claesson-Welsh, 2006).  Unlike other tyrosine kinase-dependent receptors 
that use the Ras pathway, VEGFR-2 mostly relies upon the Phospholipase-Cγ-Protein 
kinase-C pathway to activate MAP kinases (Olsson et al., 2006; Shibuya, 2006).   
 
 
    
 
Figure 1-3:  Vascular Endothelial Growth Factor Receptor-1 signalling pathway. 
 
List of abbreviations:  
Vascular Endothelial Growth Factor-A (VEGF-A), Vascular Endothelial Growth Factor 
Receptor-–2 (VEGFR-2), p38 mitogen-activated protein kinase (p38 MAPK). 
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Figure 1-4:  Vascular Endothelial Growth Factor Receptor-2 signalling pathway 
 
List of abbreviations:  
Vascular Endothelial Growth Factor-A (VEGF-A), Vascular Endothelial Growth Factor 
Receptor-–2 (VEGFR-2), Focal adhesion kinase (FAK), p38 mitogen-activated protein 
kinase (p38 MAPK), Endothelial NOS (eNOS), S6 kinase (S6K), Phospholipase C 
(PLC), Protein kinase C (PKC), Extracellular signal-regulated kinase (ERK). 
 
 
1.8 Induction of Vascular Endothelial Growth Factor by Cytokines 
Induction of VEGF mRNA and VEGF protein has been described in vivo and in vitro in 
response to several stimuli, including reactive oxygen species, glucose deprivation, 
growth factors (eg. TGF-$) (Lee et al., 2004; Zittermann and Issekutz, 2006), several 
pro-inflammatory cytokines including TNF-", IL-6 and IFN-(, and inhibition of nitric 
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oxide (reviewed in (Mura et al., 2004; Voelkel et al., 2006; Zittermann and Issekutz, 
2006)).    
 
Macrophages in the lungs can be pro- or anti-inflammatory (Pakala et al., 2002; Lamagna 
et al., 2006; Sica et al., 2006).  Type I (activated) macrophages are pro-inflammatory 
(Lamagna et al., 2006) and express pro-inflammatory cytokines.  By contrast, Type II 
(unactivated) macrophages are anti-inflammatory and moderate the inflammatory 
response, phagocytose cell waste, and promote angiogenesis (Lamagna et al., 2006).  
Research investigating the role of cytokines in angiogenesis has shown that close 
proximity of monocytes/macrophages and endothelial cells modulates the production of 
various compounds that regulate vascular function (Dahlqvist et al., 1999).  Several 
studies have demonstrated that macrophages produce endothelial cell growth factors 
including VEGFs, bFGF, and IL-8 (Hojo et al., 2000; Pakala et al., 2002), perhaps in 
conjunction with vascular smooth muscle cells.  The same data demonstrated that TLRs, 
including TLR4, play a significant role in the pro-angiogenic switch in macrophages 
(Pinhal-Enfield et al., 2003).  Given that LPS is the ligand for TLR4, these factors 
indicate a role for TLR4 in angiogenesis, particularly following endotoxin exposure.   
 
Thus, in situations of LPS-induced cell injury, endothelial cells may be stimulated to 
release VEGF-A.  With respect to immune cells, macrophages become activated to the 
Type I phenotype and are recruited to the site of injury along with other leukocytes (e.g., 
T-cells, natural killer (NK) T-cells, and neutrophils) (Sica et al., 2006).   The products 
generated during vascular remodeling induce macrophages to produce IL-12, which 
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stimulates NK T-cells to produce IFN-γ that in turn activates additional macrophages in a 
positive feedback manner (Pakala et al., 2002; Sica et al., 2006).  As indicated above, 
induction of VEGF mRNA and VEGF protein is also stimulated by IFN-γ, perhaps 
through macrophage-mediated pathways.   To further complicate these reactions, 
neutrophils also mediate T-cell responses, thus furthering the progression of 
inflammation by T-cell interaction with immune and non-immune cells by the secretion 
of T-cell specific cytokines and chemokines (Anderton and Wraith, 2002; Ludwig et al., 
2006) depending on what T-helper (Th) phenotype is differentiated.  Th1 cells regulate 
cellular immunity by secreting cytokines such as IFN- γ and TNF- α (Corthay, 2006).   
Th2 cells mediate B-cell immunity by producing IL-4, IL-5 and IL-13 (Corthay, 2006).  
A recent study demonstrated that T-cell homing to inflammatory sites (hence being in 
intimate contact with endothelial cells) stimulates VEGF secretion (Mor et al., 2004).  
The same study noted that VEGF augmented IFN-( secretion by T-cells responding to 
mitogenic or antigenic stimulus but and inhibited IL-10 secretion; thus, VEGF enhanced 
the Th1 phenotype, which may in turn activate macrophages and stimulate additional 
VEGF secretion through positive feedback.  Other studies demonstrated a link between 
VEGF and Th2 cells, whereby VEGF enhanced antigen sensitization and played a role in 
Th2-mediated lung inflammation (Lee et al., 2004).    
 
1.9 Summary 
Toll-like Receptor-4 plays a significant role in the pro-angiogenic switch in macrophages 
(Pinhal-Enfield et al., 2003), and potentially other cells expressing TLR4 such as 
epithelial cells (Kaner and Crystal, 2001).  Given that LPS is the ligand for TLR4, this 
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indicates a role for TLR4 in angiogenesis, particularly following endotoxin exposure.  
Research has demonstrated that in situations of LPS-induced cell injury, macrophages 
become activated to the Type I phenotype and are recruited to the site of injury along 
with other inflammatory cells (e.g., T-cells, natural killer (NK) T-cells, and neutrophils) 
(Sica et al., 2006) where they produce endothelial cell growth factors including VEGFs 
(Hojo et al., 2000; Pakala et al., 2002).   Induction of VEGF mRNA and VEGF protein 
has been described in vivo and in vitro in response to growth factor and pro-inflammatory 
stimuli (Lee et al., 2004; Zittermann and Issekutz, 2006).  Further research is required to 
determine specific interactions.  To further this research, we are proposing to examine 
whether exposure to swine barn air alters vascular density in the lungs and, if so, to 
determine the role of TLR4 using a murine model.    
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2.0 OBJECTIVES AND HYPOTHESES 
 
 
2.1 Objectives 
 
1) To determine whether lungs exposed to swine barn air have increased vascular 
density. 
 
2) To determine if expression of Vascular Endothelial Growth Factor-A and 
Vascular Endothelial Growth Factor Receptor-1 or Vascular Endothelial Growth 
Factor Receptor-2 are altered following exposure to swine barn air. 
 
3) To determine the role of TLR4 in swine barn air-induced angiogenesis. 
 
 
2.2 Hypothesis 
 
Exposure to swine barn air will increase vascular density in the lungs associated 
with up-regulation of the Vascular Endothelial Growth Factor pathways and 
mediated by Toll-like Receptor-4. 
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3.0 METHODS 
3.1 Animal Subjects 
To assess the role of TLR4 in endotoxin-induced angiogenesis, wild-type and TLR4 
mutant mice were obtained from Jackson Labs (Bar Harbor, Maine, USA) (Appendix A 
& Appendix B).   A summary of the genotypic and phenotypic characteristics of these 
mice is provided in Table 3-1. 
 
Table 3-1: Summary of genotypic and phenotypic characteristics of mice used. 
 
Strain C3HeB/FeJ C3H/HeJ 
Phenotype Wild-type Mutant 
TLR4 Mutation 
Status 
Wild-type;  
no mutation. 
Mutation to chromosome 4.   
 
Results in proline to histidine mutation 
in the cytoplasmic domain of TLR4; 
selectively impedes signal transduction.
TLR4 Functional Non-functional 
Lipopolysaccharide 
response allele  
Tlr4Lps-n Tlr4Lps-d 
Sensitivity to LPS Sensitive Resistant 
 
 
Both strains were inbred via sibling mating, and were agouti in appearance.  The mice 
were guaranteed virus free, and contained the retinal degeneration mutation Pde6brdl, 
causing blindness by weaning age.  Wild type and mutant mice had a similar lifespan, 
and no specialized care was required. 
 
Mutant (C3H/HeJ) mice contain a defective lipopolysaccharide (LPS) response allele 
Tlr4Lps-d, making them endotoxin-resistant.  The TLR4 defect is derived from a 
spontaneous mutation at the lipopolysaccharide response locus, which renders the mice 
unresponsive to the toxic effects of the lipid A component of LPS.  C3H/HeJ mice are 
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highly susceptible to infection by Gram-negative bacteria such as Salmonella enterica.  
Mice infected with Salmonella exhibit delayed chemokine production, impaired nitric 
oxide generation, and attenuated cellular immune responses.  Mortality in infected mice 
appears to be the result of enhanced bacterial growth within the liver Kupffer cell 
network (Appendix B). 
 
3.2 Study Design 
The inhalation model is unique to endotoxin research because it mimics the route of 
exposure for most barn workers and does not result in bacterial sepsis.  Furthermore, by 
using an inhalation model we can realistically account for epithelial-endothelial-
leukocyte interactions.  In this model, the epithelium is the first line of defense following 
exposure to barn air.  Recent data from our laboratory have shown striking parallels in 
lung dysfunction between swine barn workers and rodents exposed to swine barn air 
(Charavaryamath et al., 2005).  
 
Mice were housed in cages enriched with an exercise wheel and mouse houses, with ad 
libitum access to food and water (Figure 3-1).  In the barn, mice were suspended in cages 
approximately six feet above ground level to approximate an adult height (Figure 3-2).  
Mice were exposed to swine barn air for 1-, 5- or 20-days (eight hours/day) to mimic 
both acute and sub-chronic occupational exposures (Table 3-2).  Control animals were 
housed at the University of Saskatchewan animal care facilities for the duration of the 
project, and kept at approximately five feet above ground level.  To control for traveling 
stress, the control animals were transported to and from the barn once daily.  All 
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protocols were performed in accordance with the guidelines of the Canadian Council for 
Animal Care and were approved by the University of Saskatchewan Animal Care 
Committee. 
 
 
Table 3-2:  Experimental Design 
 
C3HeB/FeJ     (wild-type) C3H/HeJ   (mutant)  
Duration Exposure Control Exposure Control 
1 day  9  9 
5 day  9  8  9  8 
20 day  7  5  7  5 
 
Please note that the 20-day control groups were not included in data evaluation process 
because the assessed endpoints were consistent with the one- and five-day control groups. 
 
 
 
Figure 3-2: Overhead suspension of 
exposure cages in swine barn. 
 
 
 
Figure 3-1: Housing of test subjects. 
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3.3 Swine Barn Information & Dimensions 
The dry sow barn used for this experiment was located in Aberdeen, Saskatchewan.  The 
facilities were family operated, and housed approximately 70 dry sows in standing and 
group stalls (Figure 3-3).  Ventilation consisted of a series of exhaust fans, which 
appeared to be activated at all times.       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure 3-3: Swine barn layout and dimensions. 
 
 
3.4 Air Quality Assessment 
Swine barn air was analysed twice per week for both endotoxin and bacteria levels.  The 
SKC air sampler (SKC Edmonton, Canada) with binder-free glass fibre inline filter 
cassettes was used to assess entodoxin levels over the eight-hour barn exposure period.  
Flow rate was determined to be approximately 2 L/minute using the SKC Ultraflo 
Standing Stalls 
Standing Stalls 
Group Group Group Group 
~ 25 m
~ 15 m 
Cages 
Door 
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Primary Gas Flow Calibrator (See “Endotoxin Analysis”, below).  Total bacterial counts 
were obtained using the Flow Sensor Microbial Sampler (Flow Sensor, USA) with a six-
stage impinger and blood agar growth media.  Samples were taken for 20 seconds at a 
flow rate of 40 ft3/hour.  Use of the six-stage impinger allowed for determination of the 
percent of particles in each size range (Figure 3-4).  These samplers have been calibrated 
with monodisperse, unit density (1 g/cm3), spherical aerosols so that all particles 
collected, regardless of physical size, shape or density are sized aerodynamically and can 
be equated to the reference particle (Manual, 1980). Particles with a diameter of less than 
seven micrometers were considered respirable.  Knowing the air sample flow rate and the 
sampling time allows for the mean number of microbial particles per unit volume air to 
be determined.   
 
 
 
 
 
 
 
 
 
 
Figure 3-4:  Schematic 
representation of the Flow 
Sensor Microbial Sampler six-
stage impinger and the 
approximate particle sizes 
expected to impact each stage. 
 
 
 
Control samples (n=4) for both endotoxin and total bacterial counts were taken in the 
animal housing facility (Animal Control Unit A, Western College of Veterinary 
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Medicine), using the protocol outlined above.  Four (4) control SKC sample cassettes 
were taken en-route to the barn to control for contamination during animal transport.   
 
3.4.1 Endotoxin Analysis 
Cassettes were held in a dessicator at room temperature prior to use.  After exposure the 
cassettes were stored in a dessicator at 4°C.  Endotoxin concentration, given as endotoxin 
units per milligram (EU/mg) and airborne endotoxin (endotoxin units per cubic meter; 
EU/m3) were measured using the dust samples collected by the SKC air-flow sample 
cassette filters.  Total dust was determined by triplicate weighing of the filters before and 
after each sampling event.  Cassette analyses were done at the Vaccine and Infectious 
Diseases Organization (VIDO, Saskatoon) using standard protocol (Appendix C). 
 
The SKC sampler flow-rate was determined prior to and following sampling using the 
SKC Ultraflo Primary Gas Flow Calibrator.  These data were used to calculate an average 
of three readings (in mL/minute).  The readings were averaged and used in the 
calculation of actual endotoxin level (as EU/m3).  Endotoxin concentrations in the dust 
were converted to airborne endotoxin concentrations per cubic metre of air (EU/m3) using 
the following calculation:  
 
 
Endotoxin Level (EU/m3) =     (Endotoxin units/mL)     
      (Average flow in cc/min)(exposure in min)(106 mL/m3) 
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3.4.2 Total Bacterial Count Analysis 
Blood agar plates were kept at 4°C prior to use.  Plates were inserted into the six-stage 
impinger within the barn area and the Flow Sensor microbial sampler exposed the plates 
by circulating air through the impinger.  Exposures lasted 20 seconds, at a flow rate of 40 
ft3/hour.  Following exposure, plates were inverted and incubated at 37°C for 
approximately 16 hours.  Visual inspection allowed for numeration of bacterial colonies.  
Final bacterial enumeration for the barn air was based upon actual colony counts.  
Probable colony levels were predicted by the positive-hole method which corrected for 
microbial coincidence, a situation whereby multiple bacteria impact the same spot on the 
blood agar plate (Andersen, 1958).  Conversion to colony forming units per cubic meter 
(CFU/m3) was done using the following calculation: 
 
 
Bacterial Count (CFU/m3)  =   plate count or corrected count   
(flow rate in ft3/h)(1 h/60 min)(0.0283 m3/1 ft3)(time in min) 
 
 
3.5 Airway Responsiveness 
After exposures were completed animals were subjected to whole-body plethysmography 
via methacholine challenge to assess changes to airway responsiveness.  Airway 
responsiveness measures the change in airflow rate after inhalation of a broncho-
constrictor agent, such as methacholine (Kamachi et al., 2002).  Mice were placed into a 
Plexiglas tube and exposed to increasing concentrations of methacholine (0, 0.75, 1.5, 3, 
6, 12, and 24 mg methacholine/mL saline) at flow rate of 0.5 mL/minute (Figure 3-5).  
Analysis comprised evaluation of the recorded pattern of breathing before and after 
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methacholine challenge.  This technique informs the investigator about airway 
sensitization and is widely used to assess bronchial sensitivity (Lorenz et al., 2001; 
Cochran et al., 2002; Kamachi et al., 2002; Savov et al., 2002).  Changes to breathing 
after methacholine exposures were compared to control animals to determine the role of 
endotoxin in airway responsiveness. 
 
 
Figure 3-5:  Whole-body plethysmography apparatus for mice.  
 
 
3.6 Tissue Collection 
Following airway responsiveness testing, animals were injected intraperitonally with 10 
mg ketamine/kg body weight and 5 mg xylazine/kg body weight to induce anaesthesia.  
Mice were killed via cardiac puncture to allow for blood sample collection.  Immediately 
thereafter mice lungs were flushed with 3 mL Hank’s Balanced Salt Solution (HBSS; 
Sigma, H-4385).  The bronchio-alveolar lavage fluid (BALF) was collected by three 
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infusions of 1 mL HBSS, with lungs being flushed twice per infusion.  Following BALF 
collection, the right lobe of the lung was tied off and the left lobe was infused with 
immuno-electron microscopy (IEM) solution (2% paraformaldehyde, 1% 
gluteraldehyde).  Fractions of liver and lung were processed for histological analysis (4% 
paraformaldehyde solution for 24 hours, washed with PBS and blocked in paraffin wax), 
or were flash-frozen in liquid nitrogen for enzyme-linked immunosorbant assay (ELISA) 
and quantitative real-time reverse-transcriptase polymerase chain reaction (qPCR) 
analysis. 
 
3.7 Blood Total Leukocyte Count 
Blood total leukocyte counts (TLC) were obtained by hemocytometer analysis following 
red blood cell lysis using a WBC determination kit (Unopette; #365856).  Leukocytes 
were counted in four primary quadrants (each with 16 sub-quadrants), and the numbers 
were adjusted to reflect the theoretical total blood leukocyte level using the following 
equation: 
 
TOTAL LEUKOCYTES/mL =   (Sum of cells from 4 quadrants) X 50 X 103 
 
 
3.8 Broncho-Alveolar Lavage Fluid (BALF) Total Leukocyte Count 
Broncho-alveolar lavage fluid (BALF) total leukocyte counts (TLC) were obtained by 
hemocytometer analysis.  Leukocytes were easily distinguished from the smaller red 
blood cells.  Cells were counted in four primary quadrants (each with 16 sub-quadrants), 
and the numbers were adjusted to reflect the theoretical total BALF leukocyte level using  
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the following equation: 
 
TOTAL LEUKOCYTES/mL =   ((Total cells from 4 quadrants)/4) X 104 
 
3.9 Broncho-alevolar Lavage Fluid (BALF) Cytospin Analysis 
To characterize the composition of the broncho-alveolar lavage fluid (BALF) samples, 
cytospin slides were prepared.  Broncho-alveolar lavage fluid samples (approximate 
volume: 3 mL) were centrifuged at 4000 rpm for 15 minutes (Beckman-Coulter; TJ-25 
Centrifuge) at room temperature.  Supernatent was removed leaving behind a cellular 
pellet, which was suspended in 100 :L of HBSS.  The cellular solution was loaded into a 
chamber attached to a poly-L-lysine coated slide and cytocentrifuged at 1750 rpm for five 
minutes (Shandon; Cytospin3).  Slides were fixed in 100% methanol for three minutes.  
Wright’s staining allowed for leukocyte characterization via light microscopy.  
Neutrophil, macrophage and leukocyte numbers were expressed as a percentage and 
extrapolated to total BALF values per millilitre lavage fluid. 
 
3.10 Tissue Analysis 
Tissues, after processing (see Section 3.6), were prepared in the following manner: 
 
3.10.1 Hematoxylin and Eosin (H&E) Staining 
Sections (5-7 µm) were dewaxed in xylene and rehydrated in decreasing concentrations 
of ethanol followed by staining with hematoxylin (Vector; H3401) for 15 minutes.  After 
washing, the slides were dipped in acid alcohol and run under tap water for three minutes.  
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Staining with eosin for two minutes was followed by a rinse in distilled water, and 
dehydration with an ethanol series and xylene.  Cover slips were mounted. 
 
3.10.2 Immunohistochemistry (IHC) 
Sections (5-7 µm) were de-waxed in xylene and re-hydrated in decreasing concentrations 
of ethanol followed by incubation with 5% hydrogen peroxide (Sigma; H-1009) in 
methanol for 20 minutes to block endogenous peroxidase.  After rinsing in water, the 
antigenic sites were exposed by incubation to 2 mg/mL pepsin in 0.01 N HCl for 60 
minutes.  The digestive action of pepsin was terminated by washing in phosphate-
buffered saline (1 x PBS, pH 7.2).  To prevent non-specific binding, the sections were 
blocked with 1% bovine serum albumin (BSA) (Sigma; A7906) in phosphate-buffered 
saline.   
 
The consecutive sections were incubated with an appropriate antibody for 60 minutes 
followed by a secondary antibody for 30 minutes.  All antibodies and the dilutions at 
which they were used are given in Appendix D.  Horseradish peroxidase (HRP) 
conjugated streptavidin was added for 30 minutes, as necessary.  Colour was developed 
for 10 minutes with a commercial kit (Vector Laboratories, Canada) and then rinsed 
under running water for five minutes.  The IHC control sections were incubated with only 
secondary antibody or with primary anti-von Willebrand Factor (vWf) antibody. 
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3.11 Vascular Density Analysis 
Mouse lungs were stained with CD34 to visualize the capillaries of the septum.  Images 
were randomly taken of the alveolar septum proximal to bronchioles or large blood 
vessels.  Images were taken in triplicate, digitised, and evaluated in PowerPoint.  
Superimposition of a 5x5 grid (area = 310 µm2) allowed for consistent enumeration of 
microvessels per unit surface area.  The replicates were averaged and statistical analyses 
were performed.  Results were expressed as mean ± standard deviation. 
 
3.12 Enzyme-Linked Immunosorbant Assay (ELISA ) 
Appendix E contains a detailed explanation of the ELISA protocol used for both Vascular 
Endothelial Growth Factor-A (VEGF-A), and Vascular Endothelial Growth Factor 
Receptor-1 (VEGFR-1).  Briefly, the following procedure was used: 
 
3.12.1 Tissue preparation 
Tissue samples were homogenized in 1X HBSS at a dilution of 100 mg tissue per 1 mL 
HBSS.  Homogenates were centrifuged for 15 minutes (25000 rcf at 4°C, Beckman-
Coulter; TJ-25 Centrifuge) to precipitate debris.  Samples were stored at –80°C.   Tissue 
samples were thawed and further diluted in 1X HBSS (1 µL tissue sample in 3 µL HBSS) 
before being assayed. 
 
3.12.2 Broncho-alveolar Lavage Fluid (BALF) preparation 
Untreated BALF samples were frozen at –80°C.  Samples were thawed and were assayed 
undiluted. 
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3.12.3 Enzyme-Linked Immunosorbant Assay (ELISA) procedure 
Quantikine ELISA kits for mouse VEGF (R&D, Catalogue Number MMV00) and mouse 
sVEGFR-1 (R&D, Catalogue Number MVR100) were purchased.  Both assays employ 
the quantitative sandwich enzyme immunoassay technique.  Microplates came pre-coated 
with a polyclonal antibody specific for mouse VEGF or sVEGFR-1.  All samples were 
brought to room temperature before use.  Samples were assayed in triplicate.   
 
Fifty microlitres of assay diluent were added to each well, and 50 µl of standard, control 
or samples were pipetted into the wells.  The solutions were incubated for two hours at 
room temperature on a horizontal orbital microplate shaker.  Each well was aspirated and 
washed five times with the wash buffer.  One hundred microlitres of VEGF or VEGFR-1 
conjugate was added to each well and incubated at room temperature for two hours on a 
shaker.  Each well was aspirated and washed five times with wash buffer.  One hundred 
microlitres of substrate solution were added to each well and incubated for 30 minutes at 
room temperature.  One hundred microlitres of stop solution were added to each well and 
tapped gently to ensure thorough mixing.  Bound proteins yielded a blue product that 
turned yellow when the stop solution was added.  Optical density was determined using a 
BioRad 3550 microplate reader set to 450 nm.   
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3.13 Quantitative Real-time Reverse-Transcripatse Polymerase Chain Reaction 
(qPCR) 
 
3.13.1 Tissue Preparation 
RNA was extracted from tissues using a modified TRIzol/chloroform extraction protocol 
used in our laboratory (Appendix F).  Five microlitres of the extracted RNA was 
redistributed in 450 µL RNAse-free water and optically quantified using the Pharmacia 
Biotech Gene Quant II Spectrophotometer with absorbance set at 260 and 280 nm.  
Measurement endpoints included optical density at 260 nm (OD260), the ratio of OD260 
to OD280, the concentration of RNA, and the concentration of protein in the sample.  The 
purity of extracted RNA was confirmed by running a 1.0% agarose gel.  Gels were run at 
100-115 V with ethidium bromide ultraviolet fluorescence detection.  All extracts were 
used for qPCR analysis. 
 
3.13.2 Complementary DNA synthesis 
Extracted RNA was used to create complementary DNA (cDNA) using the StrataScript® 
QPCR cDNA Synthsis Kit (Stratagene, Catalogue #600554).  Poly(A)+ mRNA was 
amplified by the PTC 200 Peltier Thermal Cycler (MJ Research, Massachusetts)using 
standard PCR and oligo dT primers.  The cycles were 5 minutes at 25°C, 20 minutes at 
42°C, 5 minutes at 95°C, and terminating at 4°C until samples were collected.  The 
cDNA Master Mix allowed for production of high-quality qPCR-ready cDNA templates 
of the poly(A)+ RNA (mRNA).  Amplified cDNA was used for qPCR analysis. 
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3.13.3 Quantitative Polymerase Chain Reaction (qPCR) 
Quantitative PCR is an important method of gene expression analysis.  Synthesized 
cDNA was amplified using the StrataScript® QPCR cDNA Synthesis kit and the 
Stratagene Mx3005P real-time reverse-transcriptase PCR machine.  Primers bound to 
DNA sequences of interest allowed for gene quantification using the Brilliant® SYBR® 
Green QPCR Master Mix kit (Stratagene, Catalogue #600548).  SYBR® Green 1 dye 
binds to the minor groove of double-stranded DNA (dsDNA), and fluoresces at 520 nm 
as per manufacturer’s instructions.  Primers used for this procedure are given in 
Appendix G.   
 
3.14 Statistical Analysis 
GraphPad Prism®4 statistical software was used to evaluate all data.  Students’ t-test were 
performed to compare two paired groups.  One-way repeated measures ANOVA with 
Bonferonni post-hoc analysis were used to comapare three or more unmatched groups.  
Shapiro-Wilk normalcy test was used when necessary.  Values were expressed as mean ± 
standard error of the mean (SEM).  Significance was set at p<0.05. 
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4.0 RESULTS 
4.1 Barn Air Quality Variables 
Barn air quality variables evaluated include the total dust, in milligrams per cubic metre, 
actual and probable total bacteria, respirable bacteria, and non-respirable bacteria, all as 
colony forming units per cubic metre.  Endotoxin levels were evaluated using the SKC 
Air Sampler, and the results were given as endotoxin units per cubic metre.    Samples 
were taken twice per week for six weeks, and the results were averaged to give the mean 
(Table 4-1).  Respirable bacteria comprised the majority of the bacteria sampled, with 
means of 8.76 x 104 and 1.11 x 105 CFU/m3 for actual and probable counts, respectively.  
Total dust had a mean level of 1.87 mg/m3, containing endotoxin at a level of 3.11 x 103 
EU/m3.   Levels of bacteria and endotoxin in the Animal Care facilities and in the 
transport vehicle were below the levels of detection. 
 
 Table 4-1: Swine barn air quality variables including Total Dust (mg/m3), Total 
Bacteria (CFU/m3), Probably Total Bacteria (CFU/m3), and Endotoxin Level 
(EU/m3) expressed as the median, mean, and standard error of the mean (SEM).   
 
Parameter    Median Mean SEM 
Total Dust (mg/m3)   1.77 1.87 0.17 
Actual Total Bacteria (CFU/m3)   1.06 x 105 1.05 x 105 9.99 x 103 
Actual Respirable Bacteria (CFU/m3)   8.98 x 104 8.76 x 104 8.15 x 103 
Actual Non-respirable Bacteria (CFU/m3)   1.57 x 104 1.78 x 104 2.12 x 103 
Probable Total Bacteria (CFU/m3)   1.36 x 105 1.61 x 105 2.29 x 104 
Probable Respirable Bacteria (CFU/m3)   1.14 x 105 1.11 x 105 1.19 x 104 
Probable Non-respirable Bacteria 
(CFU/m3)   2.15 x 104 5.03 x 104 1.39 x 104 
Endotoxin Level (EU/m3)    2.44 x 103 3.11 x 103 7.25 x 102 
 
CFU = Colony forming units; EU = Endotoxin units; n = 11 
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4.2 Airway Responsiveness 
After barn exposures were completed animals were subjected to whole-body 
plethysmography to assess methacholine-induced airway responsiveness.  Mice were 
exposed to increasing concentrations of methacholine at flow rate of 0.5 mL/minute.  
Since some animals experienced significant distress during this procedure, not all animals 
were subjected to the high levels of methacholine.  As such, results are given only for the 
doses of methacholine used for all animals (0, 0.75 and 1.5 mg methacholine/mL saline). 
 
Wild-type and TLR4-mutant strains showed the same patterns of airway responsiveness 
after comparative barn exposures (Figure 4-1).  Control animals showed a dose-
dependent decrease in airway responsiveness, with air-flow decreasing to 50% of Tev1 
after exposure to 1.5 mg mechacholine.  Changes to airway responsiveness in one-day 
exposure groups were not significantly different from the control groups.  After 5-days of 
barn air exposure both wild-type and mutant groups showed increased methacholine 
sensitivity (p<0.05) with airflow being 40% lower than control groups at 1.5 mg 
methacholine exposure.  After 20-days barn air exposure wild-type and mutant groups 
showed a maximum decrease in air-flow to 20% of Tev1 after exposure to 1.5 mg 
mechacholine.   Thus, after 20-days exposure, animals were less sensitive to 
methacholine than control groups (p<0.05).   
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Figure 4-1:  Airway responsiveness for wild-type (WT) and mutant (M) animals 
after 0-, 1-, 5-, or 20-day swine barn air exposures via methacholine challenge 
(n=76).  Both strains exhibited similar patterns of methacholine response at all time 
periods.   One-day exposure groups did not differ from control groups however, 
significant decreases were observed after five days exposure (p < 0.05).  Twenty-day 
exposed groups showed lower airway responsiveness when compared to all other 
groups (p < 0.05).    Statistics were run using one-way ANOVA and Bonferroni post-
hoc analysis ( * = p<0.05 vs. control group).   
 
 
 
4.3 Broncho-alveolar Lavage Fluid (BALF) Total Leukocyte Count 
Broncho-alveolar lavage fluid (BALF) total leukocyte counts (TLC) were obtained in a 
blinded fashion by hemocytometer analysis.  Leukocytes were distinguished from the 
smaller red blood cells.  After one-day barn air exposures, wild-type mice showed a 
750% increase (p<0.05) in BALF total leukocytes compared to control groups (Figure 
4-2).  Five-day exposure groups were not significantly different from the control group, 
however, the trend toward higher leukocyte counts was preserved.  After 20-days, the 
exposed mice showed no significant difference in leukocyte count when compared to 
  37
controls.  Toll-like Receptor-4 mutant mice exhibited no significant difference in BALF 
total leukocyte count after one-, five- or 20-day barn air exposures when compared to 
control groups (Figure 4-3).   Unlike with wild-type mice, there was a trend toward 
increased leukocyte count after five-day swine barn air exposures, but this trend was not 
maintained over time.  Comparison of wild-type BALF total leukocytes against TLR4-
mutant strain responses clearly indicated a TLR4-dependent increase in leukocyte counts 
after one-day swine barn air exposure (Figure 4-4).  The mean leukocyte value in wild-
type mice after one-day barn air exposure was 2.1 times that of their mutant counterpart 
(p<0.05). 
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Figure 4-2: Broncho-alveolar lavage fluid (BALF) total leukocytes per millilitre 
BALF following 0-, 1-, 5-, or 20-day swine barn air exposures in wild-type (WT) 
animals.  A significant increase in leukocyte numbers was observed after one-day 
exposure compared to the control group (n=38).  Twenty-day exposure group was 
20% lower than observed with the one-day exposure group (n=38).  Expressed as 
mean ± standard deviation using one-way ANOVA and Bonferroni post-hoc analysis 
( * p<0.05 vs. control group;  # p<0.05 vs. WT 1-day exposure group). 
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Figure 4-3:  Broncho-alveolar lavage fluid (BALF) total leukocytes per millilitre 
BALF following 0-, 1-, 5-, or 20-day swine barn air exposures mutant (M) animals 
showed no significant differences between groups (n=38).  Expressed as mean ± 
standard deviation using one-way ANOVA and Bonferroni post-hoc analysis 
(p<0.05 vs. control group). 
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Figure 4-4:  Comparative broncho-alveolar lavage fluid (BALF) total leukocyte 
counts in wild-type (WT) and mutant (M) animals per millilitre BALF following 0-, 
1-, 5-, or 20-day swine barn air exposures (n=76).  Leukocyte infiltration decreased 
over the 20-day exposure in wild-type and mutant strains.  Expressed as mean ± 
standard deviation using one-way ANOVA and Bonferroni post-hoc analysis 
( * p<0.05 vs. matched M animal).  
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4.4 Broncho-alveolar Lavage Fluid (BALF) Cytospin Analysis 
To characterize the composition of the broncho-alveolar lavage fluid (BALF) samples, 
cytospin slides were prepared.  Wright’s staining allowed for leukocyte characterization 
via light microscopy in a blinded fashion.  Neutrophil, macrophage and leukocyte 
numbers were expressed as a percentage and extrapolated to total BALF values.  The 
following figures address the changes observed in the BALF for macrophages, 
neutrophils, and leukocytes following Wright’s staining. 
 
4.4.1 Broncho-alveolar Lavage Fluid (BALF) Absolute Macrophage Count 
A TLR4 dependent increase in BALF absolute macrophage count was observed in wild-
type mice after one-day barn air exposure (Figure 4-5), with one-day exposure groups 
having 6.5 times the number of macrophages than the control group (p<0.05).  Five-day 
and 20-day exposure groups were not significantly different from the control group.  The 
trend toward higher leukocyte counts was preserved with median leukocyte levels being 
2.6 and 0.9 that of the control group, respectively.   Toll-like Receptor-4 mutant mice 
exhibited no difference in absolute macrophage count after one-, five- or 20-day barn air 
exposures when compared to control groups (Figure 4-6).   Unlike with wild-type mice, 
there was a trend toward increased leukocyte count after five-day swine barn air 
exposures.  Comparison of wild-type responses against TLR4-mutant strain responses 
clearly indicated a TLR4-dependent increase in leukocyte counts after one-day swine 
barn air exposure (Figure 4-7).  The mean absolute macrophage count in wild-type mice 
after one-day barn air exposure was 2.4 times that of their mutant counterpart (p<0.05). 
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Figure 4-5:  Broncho-alveolar lavage fluid (BALF) absolute macrophages per 
millilitre BALF following 0-, 1-, 5-, or 20-day swine barn air exposures in wild-type 
(WT) animals showed a significant increase in macrophage numbers after one-day 
exposure (n=38). Expressed as mean ± standard deviation using one-way ANOVA 
and Bonferroni post-hoc analysis ( * p<0.05 vs. control group). 
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Figure 4-6:  Broncho-alveolar lavage fluid (BALF) absolute macrophages per 
millilitre BALF following 0-, 1-, 5-, or 20-day swine barn air exposures mutant (M) 
animals showed no significant differences between groups (n=38).  Expressed as 
mean ± standard deviation using one-way ANOVA and Bonferroni post-hoc analysis 
(p<0.05 vs. control group). 
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Figure 4-7:  Comparative broncho-alveolar lavage fluid (BALF) absolute 
macrophage counts in wild-type (WT) and mutant (M) animals per millilitre BALF 
following 0-, 1-, 5-, or 20-day swine barn air exposures. A Toll-like receptor-4 
(TR4)-dependent increase in macrophages count after one-day barn air exposure 
was observed in WT animals (n=76).  Macrophage infiltration decreased over the 
20-day exposure in wild-type and mutant strains.  Expressed as mean ± standard 
deviation using one-way ANOVA and Bonferroni post-hoc analysis ( * p<0.05 vs. 
matched M animal). 
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4.4.2 Broncho-alveolar Lavage Fluid (BALF) Absolute Neutrophil Count 
Similar to the macrophage results, a TLR4 dependent increase in BALF absolute 
neutrophil count was observed in wild-type mice after one-day barn air exposure (Figure 
4-8), with one-day exposure groups being 56.6-fold greater than control groups (p<0.05).  
Five-day and 20-day exposure groups were not significantly different from the control 
group.   Toll-like Receptor-4 mutant mice exhibited no difference in absolute neutrophil 
count after one-, five- or 20-day barn air exposures when compared to control groups 
(Figure 4-9).   There was a trend toward elevated neutrophil levels after one-day barn air 
exposure, however, this trend was not significant, and was not maintained over time.  
Comparison of wild-type responses against TLR4-mutant strain responses showed a 
TLR4-dependent increase in neutrophil counts after one-day swine barn air exposure 
(Figure 4-10).  The mean absolute neutrophil count in wild-type mice after one-day barn 
air exposure was 8.76 times greater than their mutant counterpart (p<0.05).  
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Figure 4-8:  Broncho-alveolar lavage fluid (BALF) absolute neutrophils per 
millilitre BALF following 0-, 1-, 5-, or 20-day swine barn air exposures in wild-type 
(WT) animals showed a significant increase in neutrophil numbers after 1-day 
exposure (n=38).  Expressed as mean ± standard deviation using one-way ANOVA 
and Bonferroni post-hoc analysis ( * p<0.05 vs. control group). 
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Figure 4-9:  Broncho-alveolar lavage fluid (BALF) absolute neutrophils per 
millilitre BALF following 0-, 1-, 5-, or 20-day swine barn air exposures mutant (M) 
animals showed no significant differences between groups (n=38).  Expressed as 
mean ± standard deviation using one-way ANOVA and Bonferroni post-hoc analysis 
(p<0.05 vs. control group). 
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Figure 4-10: Broncho-alveolar lavage fluid (BALF) absolute neutrophil count in 
wild-type (WT) and mutant (M) animals per millilitre BALF following 0-, 1-, 5-, or 
20-day swine barn air exposures (n=76).  Observed a Toll-like receptor-4 (TLR4)-
dependent increase in neutrophils after one-day barn air exposure.  Neutrophil 
infiltration decreased over the 20-day exposure in wild-type animals.  Mutant 
animals had no significant difference over time.    Expressed as mean ± standard 
deviation using one-way ANOVA and Bonferroni post-hoc analysis ( * p<0.05 vs. 
matched M animal). 
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4.4.3 Broncho-alveolar Lavage Fluid (BALF) Absolute Lymphocyte Count 
Similar to the macrophage and neutrophil results, a TLR4 dependent increase in BALF 
absolute lymphocyte count was observed in wild-type mice after one-day barn air 
exposure (Figure 4-11).  One-day exposure groups had 6.5 times greater lymphocyte 
count than the control group (p<0.05).  A trend toward elevated lymphocyte counts was 
preserved after five-day barn air exposure.  However, five-day and 20-day exposure 
groups were not significantly different from the control group, with median values of 
2000 and 75, respectively.  Toll-like Receptor-4 mutant mice showed a significant (1.6 
times greater, p<0.05) elevation in absolute lymphocyte count after five-day barn air 
exposures when compared to control groups (Figure 4-12).   There was a trend toward 
elevated lymphocyte levels after one-day barn air exposure, however, this trend was not 
significant, and was not maintained over the 20-day exposure period.   Comparison of 
wild-type responses against TLR4-mutant strain responses clearly indicated a TLR4-
dependent increase in lymphocyte counts after one-day swine barn air exposure (Figure 
4-13).  The mean absolute lymphocyte count in wild-type mice after one-day barn air 
exposure was approximately 2.4-fold greater than their mutant counterpart. 
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Figure 4-11:  Broncho-alveolar lavage fluid (BALF) absolute lymphocytes per 
millilitre BALF following 0-, 1-, 5-, or 20-day swine barn air exposures in wild-type 
(WT) animals showed a significant increase in lymphocyte numbers after one-day 
exposure (n=38).  Expressed as mean ± standard deviation using one-way ANOVA 
and Bonferroni post-hoc analysis ( * p<0.05 vs. control group). 
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Figure 4-12:  Broncho-alveolar lavage fluid (BALF) absolute lymphocytes per 
millilitre BALF following 0-, 1-, 5-, or 20-day swine barn air exposures mutant (M) 
animals showed no significant differences between groups (n=38).  Expressed as 
mean ± standard deviation using one-way ANOVA and Bonferroni post-hoc analysis 
(# p<0.05 vs. control group and 20-day exposure group). 
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Figure 4-13: Broncho-alveolar lavage fluid (BALF) absolute lymphocytes count in 
wild-type (WT) and mutant (M) animals per millilitre BALF following 0-, 1-, 5-, or 
20-day swine barn air exposures (n=76).  Observed a Toll-like receptor-4 (TLR4)-
dependent increase in lymphocytes after one-day barn air exposure.  Lymphocyte 
infiltration decreased over the 20-day exposure in wild-type animals.  Mutant 
animals had no significant difference over time.  Expressed as mean ± standard 
deviation using one-way ANOVA and Bonferroni post-hoc analysis ( * p<0.05 vs. 
matched M animal). 
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4.5 Blood Total Leukocyte Count 
Blood total leukocyte counts (TLC) were obtained in a blinded fashion by 
hemocytometer analysis.  Leukocytes were distinguished from the smaller red blood 
cells.   Blood total leukocyte counts exhibited similar patterns to the BALF total 
leukocyte counts.  A TLR4 dependent increase in blood total leukocytes was observed in 
wild-type mice after one-day barn air exposure (Figure 4-14), with one-day exposure 
groups having 2.6-times greater total leukocyte count than the control group.  Five- and 
20-day exposure groups were not significantly different from the control group, however, 
the trend toward higher leukocyte counts was preserved.   Toll-like Receptor-4 mutant 
mice exhibited no difference in blood total leukocyte count after one-, five- or 20-day 
barn air exposures when compared to control groups (Figure 4-15).    Comparison of 
wild-type blood total leukocytes against TLR4-mutant strain responses clearly indicated a 
TLR4-dependent increase in leukocyte counts after one-day swine barn air exposure 
(Figure 4-4).  The mean leukocyte value in wild-type mice after one-day barn air 
exposure was twice that of their mutant counterpart (p<0.05). 
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Figure 4-14:  Blood total leukocytes per millilitre blood following 0-, 1-, 5-, or 20-day 
swine barn air exposures in wild-type (WT) animals showed a significant increase in 
leukocyte numbers after 1-day exposure (n=38).  Expressed as mean ± standard 
deviation using one-way ANOVA and Bonferroni post-hoc analysis ( * p<0.05 vs. 
control group). 
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Figure 4-15:  Blood total leukocytes per millilitre blood following 0-, 1-, 5-, or 20-day 
swine barn air exposures mutant (M) animals showed no significant differences 
between groups (n=38).  Expressed as mean ± standard deviation using one-way 
ANOVA and Bonferroni post-hoc analysis (p<0.05 vs. control group). 
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Figure 4-16:  Comparative blood total leukocyte counts in wild-type (WT) and 
mutant (M) animals per millilitre blood following 0-, 1-, 5-, or 20-day swine barn air 
exposures (n=76). A Toll-like receptor-4 (TR4)-dependent increase in leukocyte 
count after one-day barn air exposure was observed in WT animals.  Leukocyte 
infiltration decreased over the 20-day exposure in wild-type and mutant strains.  
Expressed as mean ± standard deviation using one-way ANOVA and Bonferroni 
post-hoc analysis ( * p<0.05 vs. matched M animal). 
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4.6 Immunohistochemistry (IHC) 
Immunohistochemistry (IHC) is a molecular technique that can allow for qualitative 
assessment of protein expression in histological specimens.  Positive and negative 
controls sections are generated to ensure there are no problems with the methods or the 
antibodies and reagents being used.   
 
Positive (purple stain present) and negative control sections (no purple staining) for the 
immunohistochemistry are given in Figure 4-17. 
 
 
 
Figure 4-17:  Control sections used for immunohistochemistry in the alveolar 
septum: (a) positive control section (using vonWillebrand Factor; vWf), and (b) 
negative control section (using bovine serum albumin; BSA) (10x optical 
magnification).   
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4.6.1 Toll-Like receptor-4 (TLR4) 
Visualization of the lung tissue clearly showed expression of TLR4 in both the wild-type 
and mutant lungs (Figure 4-18).  As expected, the TLR4-mutant animals do express 
TLR4 at levels lower than observed in the wild-type animal (Figure 4-17).  Based upon 
the mutation described for the TLR4-mutant animal their TLR4 is hyporesponsive to 
LPS.  As such, the TLR4 carried by the mutant strain should not result in a TLR4-
mediated inflammatory response to endotoxin.  There did not appear to be induction of 
this receptor in mutant strains following multiple barn air exposures.  To confirm the 
differences in TLR4 expression between wild-type and TLR4-mutant strains, 
immunohistochemistry was performed using a goat anti-mouse TLR4 antibody.  Positive 
staining for TLR4 is observed as the dark purple areas of the lung.   
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Figure 4-18:  Comparative Toll-like Receptor-4 immuohistochemistry in the 
alveolar septum of wild-type and mutant mouse lungs following 1-, 5- or 20-day 
swine barn air exposures (40x optical magnification).  Arrows show:  A & B – TLR4 
stained pulmonary epithelial cells; C, D & F – TLR4 staining on endothelial cells; E 
– TLR4 staining on alveolar macrophage; G – high TLR4 expression on bronchiolar 
epithelial cells and endothelial cells. 
A B 
C
E F 
H G
D 
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4.6.1.1  Toll-like Receptor-4 and bronchiolar epithelial cells 
For both wild-type and mutant mouse strains, TLR4 was observed in the bronchiolar 
areas.  Wild-type mice expressed TLR4 to higher degree in the peri-bronchiolar areas, 
though staining for TLR4 was observed in both strains (Figure 4-19, arrows).  Wild-type 
mice expressed TLR4 on the apical side of the bronchiolar epithelium.  This pattern of 
expression was not observed in the mutant strain of mouse, even after 20-days barn air 
exposure (Figure 4-19, section b). 
 
 
 
Figure 4-19:  Comparative Toll-like Receptor-4 immuohistochemistry of 
bronchiolar epithelial cells in the alveolar septum of wild-type (a) and mutant (b) 
mouse lungs following 20-day swine barn air exposures (40x and 100x optical 
magnification).  Expression of TLR4 in the peri-bronchiolar areas of the alveolar 
septum was observed for both wild-type and mutant mouse strains, with wild-type 
tissues exhibiting both apical and basolateral staining (see arrows).   
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4.6.1.2  Toll-like Receptor-4 and vascular endothelial cells 
Toll-like Receptor-4 was expressed on vascular endothelial cells of both wild-type and 
mutant strains.  As observed with the bronchiolar epithelial cells, wild-type mice 
expressed TLR4 to higher degree than the mutant strains, as evidenced by darker and 
more condensed staining (Figure 4-20).   
 
 
 
Figure 4-20:  Comparative Toll-like Receptor-4 immuohistochemistry of vascular 
endothelial cells and epithelial cells in the blood vessels of the septum of wild-type 
(WT) and mutant (M) mouse lungs in control animal lungs and following 20-day 
swine barn air exposures (100x optical magnification).  Toll-like Receptor-4 is 
clearly expressed on the vascular endothelial cells of both mutant and wild-type 
animals, but to much higher degree in wild-type tissues. 
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4.2.1.3  Toll-like Receptor-4 and macrophages/monocytes 
Toll-like Receptor-4 was expressed macrophages/monocytes of wild-type animals, and 
showed marked induction of expression with multiple swine barn air exposures (Figure 4-
21).    Mutant mice macrophages/monocytes did not express TLR4 to large degree on 
macrophage/monocyte cells, and showed no change in TLR4 expression over time 
(Figure 4-21). 
 
 
 
Figure 4-21:  Comparative Toll-like Receptor-4 immuohistochemistry of 
macrophages/monocytes in the alveolar septum of wild-type (WT) and mutant (M) 
mouse lungs following 20-day swine barn air exposures compared against respective 
controls (100x optical magnification).  Toll-like Receptor-4 is up-regulated in wild-
type but not mutant mice over time, as shown. 
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4.6.2  Vascular Endothelial Growth Factor-A (VEGF-A) 
Immunohistochemical characterization of the expression of VEGF-A protein in the 
mouse lungs was done using goat anti-human VEGF-A antibody.  Positive staining for 
VEGF-A is observed as the dark purple areas of the lung tissue.   Visualization of the 
lung tissue shows high expression of VEGF-A in both wild-type and TLR4-mutant 
mouse strains in the alveolar septum, to the point of saturation (Figure 4-22).    No barn 
air exposure-related increases in VEGF-A protein expression were visually identified. 
 
 
 
 
Figure 4-22: Comparative Vascular Endothelial Growth Factor-A 
immunohistochemistry in the alveolar septum of wild-type (WT) and mutant (M) 
mouse lungs following 1-, 5- or 20-day swine barn air exposures (40x optical 
magnification). 
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4.6.3 Vascular Endothelial Growth Factor Receptor-1 (VEGFR-1) 
The possibility of changes to receptor expression following multiple barn air exposures 
was explored by IHC characterization of VEGFR-1 expression in mouse lungs.  
Characterization of the expression of VEGFR-1 was done using a goat anti-human 
VEGFR-1 antibody.  Positive staining for VEGFR-1 is observed as the dark purple areas 
of the lung tissue.  Visualization of the lung tissue shows medium- to high-expression of 
VEGFR-1 in both wild-type and mutant strains in the bronchiolar epithelium and the 
capillary endothelium (Figure 4-23).   No barn air exposure-related increases in 
VEGFR-1 protein expression were visually identified. 
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Figure 4-23:  Comparative Vascular Endothelial Growth Factor Receptor-1 
(VEGFR-1) immunohistochemistry in the alveolar septum of wild-type and mutant 
mouse lungs following 1-, 5- or 20-day swine barn air exposures (40x optical 
magnification).  Arrows show:  A – VEGFR-1 staining in the bronchiolar epithelium 
and the capillary endothelium; D – VEGFR-1 staining in the capillary endothelium 
and on macrophages; E – macrophages expressing VEGFR-1. 
A B 
C D 
E F 
G H 
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4.6.4  Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) 
The possibility of changes to receptor expression following multiple barn air exposures 
was explored by IHC characterization of VEGFR-2 expression in mouse lungs.  
Characterization of the expression of VEGFR-2 was done using rabbit anti-mouse 
VEGFR-2 antibody (Appendix D).  Positive staining for VEGFR-2 would have been 
evident as dark purple areas of the lung tissue.  Lung tissues showed no expression of 
VEGFR-2 in both wild-type and TLR4-mutant strains (as demonstrated by the lack of 
purple staining; Figure 4-24).  Lack of staining may be due to the lack of protein 
expression, or to the amount of protein being below the limit of detection for the 
VEGFR-2 antibody used.  Nonetheless, further characterization of VEGFR-2 protein 
expression was deemed unnecessary, and no ELISA was done for this receptor, though 
genetic expression was evaluated using qPCR techniques. 
 
 
Figure 4-24:  Comparative Vascular Endothelial Growth Factor Receptor-2  
(VEGFR-2) immunohistochemistry in the alveolar septum of wild-type (WT) and 
mutant (M) mouse lungs of control animals and animals following 20-day swine 
barn air exposures (40x optical magnification). 
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4.7 Vascular Density Analysis 
Mouse lungs were stained with the anti-CD34 Antibody to visualize the capillaries of the 
alveolar septum.  Images were randomly taken of the alveolar septum proximal to 
bronchioles or large blood vessels to allow for sterological evaluation of capillary 
density, identified by the number of capillary intersections.  The replicates were averaged 
and statistical analyses were performed.   
 
When evaluating the histology of control animals from both wild-type and mutant 
groups, it is apparent that there are morphological differences in septal capillary density 
between the strains (Figure 4-25).  Mutant animals appear to have larger alveoli, and less 
septum when compared to their wild-type counterparts. 
 
 
 
 
Figure 4-25: Comparative pulmonary vascular density of: a) wild-type and 
b) mutant animals stained for anti-CD34 antibody (10X optical magnification). 
 
a b
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Capillary density was increased by 127% (p<0.05) in wild-type animals after 20-days 
swine barn air exposure when compared to control group (Figure 4-26).  There was no 
change in capillary density observed in mutant animals exposed to the barn air (Figure 
4-27).  The differences in capillary density between wild-type and mutant mice were 
apparent even in the control groups.  At all time periods (control group, one-day, five-day 
and 20-day barn air exposures), the wild-type mice showed approximately 1.55-times 
higher capillary density than their mutant counterparts (p<0.05, Figure 4-28). 
 
 
 
 
 
Figure 4-26: Capillary density as capillary intersections (per 0.31 mm2) in the 
alveolar septum of wild-type (WT) animals following 0-, 1-, 5-, or 20-day barn 
exposures (n=38).   Expressed as mean ± standard deviation using one-way ANOVA 
and Bonferroni post-hoc analysis ( * p<0.05 vs. control group). 
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Figure 4-27: Capillary density as capillary intersections (per 0.31 mm2) in the 
alveolar septum of mutant (M) animals following 0-, 1-, 5-, or 20-day barn exposures 
(n=38).  Expressed as mean ± standard deviation using one-way ANOVA and 
Bonferroni post-hoc analysis ( * p<0.05 vs. control group). 
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Figure 4-28:  Comparative capillary density as capillary intersections (per 0.31 
mm2) in wild-type (WT) and mutant (M) animals following 0-, 1-, 5-, or 20-day 
swine barn air exposures (n=76).  WT animals showed significantly higher capillary 
density than M animals over all time periods.  Expressed as mean ± standard 
deviation using one-way ANOVA and Bonferroni post-hoc analysis ( * p<0.05 vs. 
matched M animal). 
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4.8 ELISA Results 
To determine whether the vascular endothelial growth factor family or its receptors were 
responsible for the observed increase in capillary density, ELISAs were performed for 
both Vascular Endothelial Growth Factor-A (VEGF-A) and VEGF Receptor-1 
(VEGFR-1).  Assays were run using either the broncho-alveolar lavage fluid (BALF) or 
mouse lung tissue.   There were no differences in VEGF-A or VEGFR-1 expression in 
BALF, and these results have not been shown. 
 
4.8.1 Vascular Endothelial Growth Factor-A (VEGF-A) 
Vascular Endothelial Growth Factor-A protein was decreased by 0.62 times (p<0.05) in 
wild-type animals following one-day barn air exposures when compared to the control 
group (Figure 4-29).  This reduction was not maintained over time, and may be the result 
of VEGF-A depletion following a pro-angiogenic event.  No changes in VEGF-A 
expression in lung tissue were observed for TLR4-mutant animals exposed to barn air for 
one-, five- or 20-day exposures when compared to the control group (Figure 4-30).  
When comparing VEGF-A expression in wild-type and TLR4-mutant mice, it is apparent 
that there are no difference in VEGF-A expression in the lung at all time periods when 
compared to their matched group (Figure 4-31).   
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Figure 4-29: Vascular Endothelial Growth Factor-A (VEGF-A) Concentrations (pg 
VEGF-A/mg tissue) in wild-type (WT) animals following 0-, 1-, 5-, or 20-day barn 
exposures (n=38).  Expressed as mean ± standard deviation using one-way ANOVA 
and Bonferroni post-hoc analysis ( * p<0.05 vs. control group). 
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Figure 4-30: Vascular Endothelial Growth Factor-A (VEGF-A) concentrations (pg 
VEGF-A/mg tissue) in mutant (M) animals following 0-, 1-, 5-, or 20-day barn 
exposures (n=38).  Expressed as mean ± standard deviation using one-way ANOVA 
and Bonferroni post-hoc analysis ( * p<0.05 vs. control group). 
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Figure 4-31:  Comparative Vascular Endothelial Growth Factor-A (VEGF-A) 
concentration (pg VEGF-A/mg tissue) in wild-type (WT) and mutant (M) animals 
following 0-, 1-, 5-, or 20-day swine barn air exposures (n=76).  Expressed as mean ± 
standard deviation using one-way ANOVA and Bonferroni post-hoc analysis ( * 
p<0.05 vs. control group). 
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4.8.2 Vascular Endothelial Growth Factor Receptor-1  (VEGFR-1) 
There were no changes to the expression of VEGFR-1 to lung tissues in wild-type 
animals exposed to barn air for one-, five-, or 20-days when compared to the control 
group (Figure 4-32).  No changes in VEGFR-1 expression in lung tissue were observed 
for mutant animals exposed to barn air for one-, five- or 20-day exposures when 
compared to the control group (Figure 4-33).  When comparing VEGFR-1 expression in 
wild-type and mutant mice, there were no differences in VEGFR-1 expression in the lung 
at all time periods when compared to their matched group (Figure 4-34). 
 
 
 
 
Figure 4-32: Vascular Endothelial Growth Factor Receptor-1 (VEGFR-1) 
concentrations (pg VEGFR-1/mg tissue) in wild-type (WT) animals following 0-, 1-, 
5-, or 20-day barn exposures (n=38).  Expressed as mean ± standard deviation using 
one-way ANOVA and Bonferroni post-hoc analysis ( * p<0.05 vs. control group). 
 
 
  76
 
 
Figure 4-33: Vascular Endothelial Growth Factor Receptor-1 (VEGFR-1) 
concentrations (pg VEGFR-1/mg tissue) in mutant (M) animals following 0-, 1-, 5-, 
or 20-day barn exposures (n=38).  Expressed as mean ± standard deviation using 
one-way ANOVA and Bonferroni post-hoc analysis ( * p<0.05 vs. control group). 
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Figure 4-34:  Comparative Vascular Endothelial Growth Factor Receptor-1 
(VEGFR-1) concentration (pg VEGFR-1/mg tissue) in wild-type (WT) and mutant 
(M) animals following 0-, 1-, 5-, or 20-day swine barn air exposures (n=76).  
Expressed as mean ± standard deviation using one-way ANOVA and Bonferroni 
post-hoc analysis ( * p<0.05 vs. control group). 
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4.9 Real-time Reverse Transcriptase-Polymerase Chain Reaction (qPCR) 
Changes to the capillary density were observed in wild-type animals after 20-day barn air 
exposures.  However, these changes could not be attributed to protein expression of 
VEGF-A or its receptors, as evidenced by ELISA results.  Thus, quantitative real-time 
reverse transcriptase-polymerase chain reaction (qPCR) assays were run for VEGF-A, 
and two of its receptors, VEGFR-1 and VEGFR-2.  The purpose of these assays was to 
determine whether changes to messenger RNA (mRNA; poly(A)+ RNA) expression in 
mouse lungs could account for morphological changes seen following barn air exposures. 
 
Results are given as a Relative Quantity because the Stratagene MX3005P QPCR 
apparatus is restricted to determining fluorescence relative to a reference fluorescence 
(set at dRn = 1.0).  In all cases, the reference for relative fluorescence is the wild-type 
control group (designated WT Control). 
 
 
4.9.1 qPCR Results for Vascular Endothelial Growth Factor-A 
Analysis of VEGF-A mRNA expression wild-type and TLR4-mutant mice lung (n=3 per 
group) showed that the relative fluorescence for VEGF-A mRNA was higher in wild-type 
animals over all time periods.  Though the relative fluorescence did not appear to 
increase greatly, the biological significance of this increase could not be determined.  
Toll-like Receptor-4 mutant mice showed fluorescence for VEGF-A mRNA, however, 
this fluorescence was approximately one-third lower that of the wild-type animals (Figure 
4-35).  This result appears to reflect the morphological differences observed in septal 
density between wild-type and TLR4-mutant mice. 
  79
0
0.2
0.4
0.6
0.8
1
1.2
1.4
WT Control WT 1-day Exposure WT 5-day Exposure WT 20-day
Exposure
M Control M 1-day Exposure M 5-day Exposure M 20-day Exposure
R
el
at
iv
e 
Q
ua
nt
ity
 o
f V
EG
F-
A
 (d
R
n)
 
Figure 4-35:  Comparative relative fluorescence (dRn) for Vascular Endothelial 
Growth Factor-A (VEGF-A) mRNA in wild-type (WT) and mutant (M) animals 
following 0-, 1-, 5-, or 20-day swine barn air exposures (n=24).  
 
 
 
4.9.2 qPCR Results for Vascular Endothelial Growth Factor Receptor-1 
Analysis of VEGFR-1 mRNA expression wild-type and TLR4-mutant mice lung (n=2 
per group) showed wild-type control and TLR4-mutant control groups showed no 
difference in their VEGFR-1 mRNA expression (baseline expression).   The relative 
fluorescence for VEGFR-1 was increased in wild-type animals over all exposure periods 
(Figure 4-36).  One-, five- and 20-day exposures increased VEGFR-1 mRNA expression 
by 3.1, 2.75 and 2.20 folds compared to the wild-type control animals.  Toll-like 
Receptor-4 mutant mice showed fluorescence for VEGFR-1 mRNA.  As opposed to 
observations in wild-type animals, the relative quantity of VEGFR-1 mRNA in TLR4-
mutant animals decreased by half after 1-day swine barn air exposure.  The relative 
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quantity of VEGFR-1 mRNA rebounded to approximately baseline levels after 20-days 
barn air exposure.   
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Figure 4-36:  Comparative relative fluorescence (dRn) for Vascular Endothelial 
Growth Factor Receptor 1 (VEGFR-1) mRNA in wild-type (WT) and mutant (M) 
animals following 0-, 1-, 5-, or 20-day swine barn air exposures (n=16). 
 
 
4.9.3 qPCR Results for Vascular Endothelial Growth Factor Receptor-2 
Analysis of VEGFR-2 mRNA expression wild-type and TLR4-mutant mice lung (n=2 
per group) showed wild-type control and TLR4-mutant control groups showed no 
difference in their VEGFR-2 mRNA expression (baseline expression).   The relative 
fluorescence for VEGFR-2 was increased in wild-type animals over all exposure periods, 
with the highest levels, 1.85 times that of control groups, observed after 20-day barn air 
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exposures (Figure 4-37).  TLR4-mutant mice showed fluorescence for VEGFR-2 mRNA.  
A similar pattern of VEGFR-2 mRNA expression was observed, when compared to the 
wild-type animals, though levels never reached those observed for the wild-type animals 
(maximum increase of 1.43 times that of M control group).  However, 20-day exposures 
to the barn air appeared to induce higher levels of VEGFR-2 mRNA in the wild-type 
mice compared to the mutant animals 
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Figure 4-37:  Comparative relative fluorescence (dRn) for Vascular Endothelial 
Growth Factor Receptor 2 (VEGFR-2) mRNA in wild-type (WT) and mutant (M) 
animals following 0-, 1-, 5-, or 20-day swine barn air exposures (n=16). 
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5.0 DISCUSSION AND CONCLUSIONS 
5.1  Air Quality 
The swine barn air contained bacteria and endotoxin.  Though the actual composition of 
Gram-negative vs. Gram-positive bacteria was not quantified, bacterial enumeration 
showed that there was a median of 105 500 CFU/m3 in the barn atmosphere.  Dust 
sampled from the barn air using the SKC air sampler contained high levels of endotoxin, 
confirming the presence of Gram-negative bacteria.  After eight-hour sample collection 
the median endotoxin level in the barn was 1.66 x 103 EU per mg dust, which is 
approximately 500 times the endotoxin level in ambient indoor air (Long et al., 2001; 
Schulze et al., 2006).   
 
Of the bacteria, 85% had a diameter of less than 7 µm and were respirable.   Due to sub-
optimal sampler performance, the percentage of respirable bacteria may be under-
represented in the data.  Optimal flow rate for the Flow Sensor Microbial Sampler is 
60 ft3/hour, but all samples were run at 40 ft3/hour.  Due to decreased flow rate the 
bacterial particles had a greater likelihood for impacting the higher stages of the six-stage 
impinger, resulting in higher colony counts in the larger particle-size stages (Stage 1 
$7 µm, Stages 2-6 < 7 µm (Figure 3-4)).  As such, the percentage of particles in each size 
range will be skewed toward higher percentage of large particles, with particles <7 µm 
being considered respirable.  Bacteria were quantified on all 6 of the stages, clearly 
demonstrate that bacteria and endotoxin are entering the deep lung.  Therefore, for the 
purposes of this research the skewed results have no bearing because the intention of the 
measurements was to show that bacterial particles were able to penetrate the deep lung.  
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5.2 Evaluation of the Model 
Inhalation and injection models are frequently used to determine the effects of purified 
LPS on the lung (George et al., 2001; Lorenz et al., 2001; Moreland et al., 2002; Savov 
et al., 2002; Brass et al., 2003; Savov et al., 2003; Brass et al., 2004; Hollingsworth et 
al., 2004; Savov et al., 2005; Brass et al., 2007).  The approach used in this study is novel 
in that it uses a whole-barn air model to determine the effects of LPS on pulmonary 
inflammation following multiple barn air exposures.  By using an inhalation model rather 
than an injection model we were able to account for epithelial-endothelial-leukocyte 
interactions, with the epithelium being the first line of defence following exposure to barn 
air.   In contrast to the majority of published endotoxin studies whereby the subjects 
inhale pure LPS to mimic the effects of endotoxin-rich barn air, we exposed the mice 
directly to swine barn air.  This allowed us to account for the effects of other barn air 
components such as dust, bacteria and irritant chemicals including ammonia and 
hydrogen sulphide (Zhang, 1998), which are also risk factors for the development of 
chronic respiratory symptoms and lung dysfunction (Zejda et al., 1993; Zejda et al., 
1994).   
 
To confirm whether the model selected for this experiment was appropriate to 
determining the differences in angiogenesis for wild-type and TLR4-mutant mice to barn 
air stimuli, several immunological and histological variables were evaluated.   The 
following sections outline observations made between the strains used for this model with 
respect to airway responsiveness, TLR4 expression, the cellular inflammatory response, 
and finally the vascular density parameters following multiple swine barn air exposures. 
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5.2.1 Airway Responsiveness 
Changes to airway responsiveness were independent of TLR4, as demonstrated by the 
fact that wild-type and mutant strains showed the same patterns of airway responsiveness 
after comparative barn exposures.  Control animals showed a dose-dependent decrease in 
airway responsiveness, with air-flow decreasing to 50% of Tev1 after exposure to 1.5 mg 
methacholine.  Changes to airway responsiveness in one-day exposure groups were not 
significantly different from the control groups.  After five days of barn air exposure both 
wild-type and mutant groups showed increased methacholine sensitivity (p<0.05) with 
airflow being 40% lower than control groups at 1.5 mg methacholine exposure.  
Conversely, 20-days barn air exposures had wild-type and mutant groups exhibiting a 
maximum decrease in air-flow to 20% of Tev1 after exposure to 1.5 mg methacholine.  
Thus, after 20-days exposure, animals were less sensitive to methacholine than control 
groups (p<0.05).   
 
The observed airway responsiveness patterns are independent of TLR4.  The changes to 
methacholine sensitivity may have been the result of chemical or physical irritation by 
barn air components other than endotoxin.  Examples of these types of chemicals are 
ammonia and hydrogen sulphide (Zhang, 1998), both of which form acids upon contact 
with water found in the airways.  The resulting acids may damage the airway epithelium, 
resulting in irritation, and causing increased airway sensitivity after barn air exposure.  
The decreased airway sensitivity observed after 20-day swine barn air exposure may be 
due to alteration to the airway epithelium, to the sensitivity of the autonomic nervous 
system, or to the acid-base balance of the tissues.   
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These data differ from the results obtained from mice exposed to sub-acute 
concentrations of pure LPS where airway responsiveness was shown to be dependent on 
intact TLR4 and showed no dampening even after multiple exposures (Schwartz, 2002). 
The precise reasons for these differences are not clear but it may largely be due to 
biochemical complexity of the barn air compared to pure LPS.  
 
5.3 Expression of Toll-like Receptor-4 
Immunohistochemical analysis of the tissues clearly showed that TLR4 was expressed in 
the wild-type mouse tissues (bronchiolar epithelial cells, peribronchiolar areas, 
monocytes/macrophages, vascular endothelial cells).  Mutant mice also expressed TLR4 
in the airway and vascular cells, albeit at lower levels compared to the wild-type animals.  
Mutant (C3H/HeJ) mice contain a defective lipopolysaccharide (LPS) response allele 
Tlr4Lps-d, making them endotoxin-resistant.  The TLR4 defect is derived from a 
spontaneous mutation at the lipopolysaccharide response locus, which renders the mice 
unresponsive to the toxic effects of the lipid A component of LPS.   Thus, there was no 
up-regulation of TLR4 expression in the mutant mice following barn air exposures.  
These results were expected in the mutant strain and were consistent with previously 
published studies (Nill et al., 1995; Ryan and Vermeulen, 1995), and can be attributed to 
the non-responsive nature of the TLR4 being expressed.    
 
5.4 Evaluation of the Cellular Inflammatory Response 
Activation of the TLR4 signalling pathway results in pro-inflammatory stimuli, as 
previously discussed (see Introduction).  To confirm the activation of these pathways in 
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the wild-type animal, and more specifically to determine the level of TLR4-mediated 
inflammatory response in the endotoxin hyporesponsive TLR4-mutant animals, we 
evaluated of the number of leukocytes in the broncho-alveolar lavage fluid (BALF) and 
the blood.  Further to general leukocyte counts, absolute macrophage/monocyte, 
neutrophil and lymphocyte counts were performed and showed induction of the 
inflammatory response in the tissue following endotoxin exposure.  Since TLR4 is 
involved with the innate immune response we expected to see increased 
macrophage/monocyte recruitment to the tissues exposed to endotoxin when compared to 
other cell-types.   
 
Total leukocyte counts in BALF and the blood of exposed wild-type animals showed a 
spike in the number of cells after one-day barn air exposures.  After one-day barn air 
exposures, wild-type mice showed a 750% increase (p<0.05) in BALF total leukocytes 
and a 2.6-fold increase in blood total leukocytes when compared to control groups.  Five-
day exposure groups were not significantly different from the control groups, however 
the trend toward higher leukocyte counts was preserved.  After 20-days, the exposed 
mice showed no significant difference in leukocyte count when compared to controls.  
The decrease in leukocyte counts in both blood and BALF may be attributed to endotoxin 
tolerance and was not unexpected.  The spike in leukocyte counts after one-day barn air 
exposure was not observed in the TLR4-mutant animals, indicating a TLR4-dependent 
response.   
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Further evaluation of the leukocyte profile was done through BALF cytospin analysis, 
which allowed for characterization of monocytes/macrophages, neutrophils and 
lymphocytes following Wright’s staining.  Neutrophil, macrophage and leukocyte 
numbers were expressed as a percentage and extrapolated to total BALF values.  In all 
cases, the cellular trends were similar to the total BALF and blood counts, with dramatic 
increases in cell counts after one-day barn air exposures in wild-type animals.  
Monocytes and macrophages were by far the major component of the cellular immune 
response, with median values increasing by 6.5-fold after one-day wild-type barn air 
exposure. 
 
Neutrophils experienced a 56.6-fold increase after one-day barn air exposures when 
compared to their control groups.  The remainder of the cells counted were classified 
generally as lymphocytes, and the numbers increased by 6.5-times when compared to 
their control group.  These increases were attenuated over time, likely due to endotoxin 
tolerance.  Toll-like Receptor-4 mutant mice did not exhibit these types of innate immune 
response, which confirms that the TLR4 expressed in their tissues is non-functional or 
hyporesponsive.    
 
These results show that TLR4 plays a critical role in lung inflammation following 
exposures to swine barn air.  This result is in accordance with our hypothesis and with the 
high concentrations of endotoxin detected in the barn air.  An interesting finding was that 
some inflammation was observed in the lungs of mutant animals.  This may be the result 
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of other barn air constituents such as ammonia and dust, or it may be the result of lesser 
Toll-like Receptor pathways and bears further investigation.  
 
5.5 Confirmation of the Model 
Evaluation of immunological and histological differences between wild-type and TLR4-
mutant mice strains confirmed that this model exhibits appropriate TLR4 expression and 
inflammatory responses suitable to this experiment.   Wild-type animals demonstrated an 
immune response consistent with TLR4 mediated innate immunity following endotoxin 
exposure.  Toll-like Receptor-4 mutant strains did not show an immune response 
following identical swine barn air exposures, thereby confirming that the TLR4-mutant 
strain does not exhibit TLR4-mediated responses following swine barn air exposures.  
Thus, any differences in angiogenesis observed between the wild-type and TLR4-mutant 
mouse strains following multiple swine barn air exposures may be attributed to 
endotoxin-induced TLR4-mediated effects. 
 
5.6 Vascular Density Analysis  
Mouse lungs were stained with anti-CD34 antibody to visualize the capillaries of the 
alveolar septum.  Images were randomly taken of the alveolar septum proximal to 
bronchioles or large blood vessels and evaluated by a modified sterological technique that 
allowed for consistent enumeration of microvessels per unit surface area.  Unfortunately, 
this method did not allow for quantification of the relative percentage of epithelial cells to 
endothelial cells in the alveolar septum.  As such, it is impossible to determine whether 
there are proportionally more endothelial cells (i.e., as the result of angiogenesis) in the 
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septum, or simply more septum.  These types of results could best be obtained through 
flow cytometry but it was not possible to run flow cytometry in our experiment due to a 
conflict with tissue processing techniques.  Nonetheless, the results obtained do give an 
idea of inherent differences in the morphology between lungs from wild-type and TLR4-
mutant mice, and the changes that occur in the lung following multiple exposures to 
endotoxin in swine barn air. 
 
5.6.1 Morphological differences between strains 
Morphological differences in the alveolar septum were observed between wild-type and 
TLR4-mutant mice.  Wild-type mice had approximately 1.55-times the septal density of 
their TLR4-mutant counterparts (p<0.05).  The differences in septal density were 
unexpected, and were observed for all groups including the control groups.  To the best 
of our knowledge, a difference in septal density or air space volume between the 
C3HeB/FeJ and C3H/HeJ mouse strains has never been reported in the literature.  
Dissimilarity in pulmonary architecture is important for the design of toxicologically-
based respiratory studies.  Differences in pulmonary surface area and tidal volume may 
affect the dose of toxicant an animal receives over a given period of exposure, thus 
rendering this model inappropriate for toxicological, or physiological comparison. 
 
5.6.2 Changes to vascular density after multiple barn air exposures 
With respect to TLR4-mediated changes to vascular density, results indicated that 
capillary density was increased by 127% (p<0.05) in wild-type animals after 20-days 
swine barn air exposure when compared to control groups.  This is consistent with 
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previous studies of angiogenesis in rats following exposure to the bacteria Mycoplasma 
pulmonis (Dahlqvist et al., 1999), and may be related to the presence of activated 
macrophages or other cell types, including endothelial cells.  As previously stated, TLRs, 
including TLR4, have been demonstrated to play a significant role in the pro-angiogenic 
switch in macrophages (Pinhal-Enfield et al., 2003).  The observed increase in capillary 
density was not seen in mutant animals subjected to the same experimental conditions.   
Given that LPS is the ligand for TLR4, and that only the wild-type mice showed an 
increase in lymphocyte count and exhibited any change to vascular density in the alveolar 
septum, we can conclude 1) that endotoxin is contributing to the observed change in 
vascular density, and 2) that TLR4 plays a role in septal angiogenesis following swine 
barn air exposures.    Damage to the lung via endotoxin has been demonstrated to induce 
the transcription of VEGF mRNA, and the release of VEGF (Hahn, 2003), thus 
elucidation of the role of VEGF and its two receptors in endotoxin-induced angiogenesis 
was the next logical step for this experiment. 
 
5.7 Expression of pro-angiogenic factors 
To determine whether Vascular Endothelial Growth Factor-A (VEGF-A), or two of its 
receptors, VEGFR-1 and VEGFR-2, played a role in the changes to vascular density 
observed in wild-type animals after 20-day swine barn air exposures, several molecular 
techniques were employed.  Immunohistochemistry (IHC) allowed for qualitative 
evaluation of VEGF-A, VEGFR-1 and VEGFR-2 protein expression.  Enzyme-linked 
Immunosorbant Assays (ELISAs) were performed to quantify the proteins of interest 
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identified with the IHC techniques.  Evaluation of gene regulation was done using 
quantitative real-time reverse-transcriptase PCR (qPCR) for all three proteins of interest.   
 
5.7.1 Vascular Endothelial Growth Factor-A (VEGF-A) 
Immunohistochemistry was not sensitive enough to show differences in protein 
expression of VEGF-A in the lung.  All groups for both wild-type and TLR4-mutant 
strains showed high levels of VEGF-A expression.  This was not unexpected (Shifren et 
al., 1994; Corne et al., 2000; Voelkel et al., 2006), however, to quantify the expression of 
VEGF-A protein in the lungs ELISAs were performed.  Vascular Endothelial Growth 
Factor-A was found in wild-type lung tissues at a median level of approximately 10 pg 
VEGF-A/mg lung tissue.  The ELISAs demonstrated that VEGF-A protein was decreased 
by 0.62 times (p<0.05) in wild-type animals following one-day barn air exposures when 
compared to controls.  This reduction was not maintained over time, and may be the 
result of VEGF-A depletion following a pro-angiogenic event.  No changes in VEGF-A 
expression in lung tissue (average median: 9 pg VEGF-A/mg lung tissue) were observed 
for TLR4-mutant animals exposed to barn air for one-, five- or 20-day exposures when 
compared to the control group.   
 
A possible reason for the decrease in VEGF-A expression after one-day swine barn air 
exposure is the initiation of angiogenesis.  If VEGF-A was acting in a pro-angiogenic 
fashion, the level of the mitogenic protein may have been depleted in the tissue where it 
was being used.  Thus, if translation of the protein was not immediately up-regulated 
within the tissue, it is possible that VEGF-A protein levels in the lung may have been 
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decreased for a short period of time.  To determine whether VEGF-A translation was up-
regulated, evaluation of VEGF-A mRNA expression was done using qPCR techniques.  
Analysis showed that the relative fluorescence for VEGF-A mRNA was higher in wild-
type animals over all time periods, and increased with barn air exposures.  Though the 
relative fluorescence in wild-type animals did not increase greatly, the biological 
significance of this increase could not be determined.  It is possible that the increase in 
mRNA translation was due to an inflammatory cell-mediated increased VEGF-A activity 
(and hence, angiogenesis) in the lung (Mor et al., 2004).  Toll-like Receptor-4 mutant 
mice showed fluorescence for VEGF-A mRNA, however, this fluorescence was 
approximately one-third lower that of the wild-type animals.  The lower VEGF-A mRNA 
expression may account for morphological differences observed in septal density 
observed between wild-type and TLR4-mutant mice (Nill et al., 1995).  These results 
could be evidence of a role for VEGF-A in endotoxin-induced angiogenesis in mice 
expressing a functional TLR4. 
 
5.7.2 Vascular Endothelial Growth Factor Receptors (VEGFRs) 
Both VEGFR-1 and VEGFR-2 were evaluated in this experiment.  The possibility of 
changes to receptor expression following multiple barn air exposures was explored by 
IHC characterization of VEGFR-1 expression in mouse lungs.  Vascular Endothelial 
Growth Factor Receptor-1 was expressed throughout the lungs of both wild-type and 
TLR4-mutant mice on the endothelial cells and the surface of macrophages.  Expression 
of VEGFR-1 on these cell types was expected because VEGFR-1 is involved in vascular 
organization and the migration of macrophages toward VEGF-A (Fong et al., 1999; 
  93
Olsson et al., 2006; Shibuya, 2006; Shibuya and Claesson-Welsh, 2006).  ELISA 
techniques indicated that VEGFR-1 protein expression did not change over time in either 
wild-type or TLR4-mutant mice strains.  The approximate median level of VEGFR-1 in 
the lung tissue was 150 pg VEGFR-1/mg lung tissue.  There was no apparent up- or 
down-regulation of VEGFR-1 protein expression following exposure to swine barn air.  
Analysis of VEGFR-1 mRNA expression wild-type and TLR4-mutant mice lung by 
qPCR showed that the relative fluorescence for VEGFR-1 was increased in wild-type 
animals over all exposure periods.  One-day exposure groups had VEGFR-1 mRNA 
increased by 3.1-fold, with mRNA expression being slightly decreased after five- and 20-
day exposures.  Though there is increased mRNA transcription, it does not necessarily 
follow that there would be increased VEGFR-1 translation, however, this could partly 
explain the increase in vascular density observed in wild-type animals after 20-day swine 
barn air exposures.  Though the specific roles of VEGFR-1 are still being elucidated, it 
has been suggested that this receptor is involved in vascular organization and the 
migration of macrophages toward VEGF-A (Fong et al., 1999; Olsson et al., 2006; 
Shibuya, 2006; Shibuya and Claesson-Welsh, 2006).  Toll-like Receptor-4 mutant mice 
showed fluorescence for VEGFR-1 mRNA.  However, as opposed to observations in 
wild-type animals, the relative quantity of VEGFR-1 mRNA in TLR4-mutant animals 
decreased by one-half after 1-day swine barn air exposure.  Thus, there appears to be a 
role for VEGFR-1 in the changes to vascular density observed in the lungs of wild-type 
mice under conditions of multiple swine barn air exposures. 
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The possibility of changes to VEGFR-2 receptor expression following multiple barn air 
exposures was explored by IHC characterization.  VEGFR-2 was not observed through 
histological analyses.  Lack of staining may be due to the lack of protein expression, or to 
the amount of protein being below the limit of detection for the VEGFR-2 antibody used.  
Given that VEGFR-2 plays no role in vascular organization (Fong et al., 1995; Mura et 
al., 2004; Olsson et al., 2006; Shibuya, 2006; Shibuya and Claesson-Welsh, 2006), it is 
more likely that this protein is not being expressed in the adult mouse lung and further 
characterization of VEGFR-2 protein expression was deemed unnecessary.  No ELISA 
was done for this receptor for the reasons stated above, though genetic expression was 
evaluated using qPCR techniques.  Analysis of VEGFR-2 mRNA expression wild-type 
and TLR4-mutant mice lung showed wild-type control and TLR4-mutant control groups 
showed no difference in their VEGFR-2 mRNA expression (baseline expression).   The 
relative fluorescence for VEGFR-2 mRNA was increased in wild-type animals over all 
exposure periods, with the highest levels, 1.85 times that of control groups, observed 
after 20-day barn air exposures.  Toll-like Receptor-4 mutant mice showed fluorescence 
for VEGFR-2 mRNA.  A similar pattern of VEGFR-2 mRNA expression was observed in 
TLR4-mutant strains when compared to the wild-type animals, though levels never 
reached those observed for the wild-type animals (maximum increase of 1.43 times that 
of mutant control group).  Based upon these results, but primarily upon the fact that 
protein expression was not observed in either strain of mouse lungs after any time point, 
it was concluded that VEGFR-2 is not expressed at levels that would result in pro-
angiogenic events in the mouse lung following multiple swine barn air exposures. 
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Though there appears to be a role for VEGF-A and VEGFR-1 in the manifestation of 
TLR4-induced angiogenesis in the lung, it is important to caution that these pro-
angiogenic factors may not be the not the major contributors to the vascular changes, nor 
should they explain them in their totality.  
 
5.8 Conclusions 
In conclusion, we have determined that the murine inhalation model for endotoxin-
induced angiogenesis was appropriate for this type of study.  The wild-type mouse 
(C3HeB/FeJ) expressed a functional TLR4, and exhibited appropriate innate immune 
responses following multiple swine barn air exposures.  The TLR4-mutant mouse 
(C3H/HeJ) expressed TLR4 to low level, but this TLR4 was non-functional or 
hypo-responsive, as evidenced by a lack of immunological response following endotoxin 
exposure in the swine barn.   
 
Using this model, we determined that TLR4 does play a role in changes to vascular 
density following multiple swine barn air exposures.  This conclusion was reached 
because the increase in vascular density was only observed in the wild-type mouse strain 
after multiple swine barn air exposures, and after an appropriate biological timeframe had 
passed.  As previously stated, TLR4 has been demonstrated to play a significant role in 
the pro-angiogenic switch in macrophages (Pinhal-Enfield et al., 2003).  Given that LPS 
is the ligand for TLR4, and that only the wild-type mice exhibited any change to vascular 
density in the alveolar septum, we can conclude that TLR4 plays a role in septal 
angiogenesis following swine barn air exposures.     
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Damage to the lung via endotoxin has been demonstrated to induce the release of VEGF 
(Hojo et al., 2000; Pakala et al., 2002), perhaps due to increased inflammatory or 
epithelial cell activity (Mura et al., 2004; Voelkel et al., 2006; Zittermann and Issekutz, 
2006).   A direct correlation between endotoxin damage and VEGF-A activity was not 
observed using our mouse model, however, this type of relationship can be supported by 
the fact that VEGF-A protein levels were decreased after one-day swine barn air 
exposure in wild-type animals.  This indicates that the VEGF-A protein is temporarily 
being depleted in response to a pro-angiogenic event (Shifren et al., 1994).  To 
compensate for the depletion of VEGF-A protein in the lung, transcription of VEGF-A 
mRNA was up-regulated in wild-type animals after all swine barn air exposure periods.  
Thus, VEGF-A is translated at a higher frequency and is involved in the vascular changes 
observed in LPS-sensitive mice after multiple swine barn air exposures.   
 
To further support the role for VEGF-A in septal angiogenesis following barn air 
exposures, VEGFR-1 showed increased mRNA transcription over all time points.  One-
day exposure groups had VEGFR-1 mRNA increased by 3.1-fold, with mRNA 
expression being slightly decreased after five- and 20-day exposures.  Thus, there appears 
to be an endotoxin-induced TLR4-mediated role for VEGFR-1 in the changes to vascular 
density observed in the lungs of wild-type mice under conditions of multiple swine barn 
air exposures.  Vascular Endothelial Growth Factor Receptor-2 is not affected by 
endotoxin-induced TLR4-mediated initiation of angiogenesis. 
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C – Endotoxin Analysis Protocol (VIDO)  
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F – RNA extraction with TRIZOL reagent 
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Appendix A: Information on the wild-type mouse strain (C3HeB/FeJ) 
 
From:  http://jaxmice.jax.org/strain/000658.html 
 
JAX Mice Datasheet 
Strain Name:  C3HeB/FeJ 
Stock Number:  000658 
 
Product Information 
 
Strain Details 
Type Inbred Strain 
 Additional information on Inbred Strains.
TJL Mating System Sibling x Sibling         (Female x Male) 
  
Species laboratory mouse 
H2 Haplotype k 
Generation F201 (14-DEC-06)  
Appearance 
agouti 
Related Genotype: A/A  
Important Note 
This strain does not carry mouse mammary tumor virus (MMTV). See JAX Notes, May 
2000, #480. This strain is also homozygous for the retinal degeneration allele Pde6brd1. 
See article "Genetic Background Effects: Can Your Mice See?", JAX Notes Spring 2002, 
No. 485.  
Gene & Allele Details 
Allele Symbol Pde6brd1 
Allele Name retinal degeneration 1 
Common Name(s) rd; rd-1; rodless retina;  
Gene Symbol and Name Pde6b, phosphodiesterase 6B, cGMP, rod receptor, beta 
polypeptide  
Chromosome 5 
Gene Common Name(s) CSNB3; PDEB; Pdeb; nmf137; phosphodiesterase, cGMP, 
rod receptor, beta polypeptide; r; rd; rd-1; rd1; rd10; retinal 
degeneration; retinal degeneration 1; retinal degeneration 10;  
 
General Note Pde6brd1, retinal degeneration 1, recessive. Formerly r, rd, rd1. 
A mutation causing retinal degeneration described by 
Bruckner (J:25576) and by Tansley (J:15333) in various 
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stocks was later found to be present in many inbred strains 
(J:114). Keeler (J:5007) thought it to be identical with the 
rodless retina mutation he had described in 1924 (J:24999); 
the identity has recently been proven by analyses of DNA 
from Keeler's original slides (J:15231).  
Homozygotes are fully viable and fertile.Eyes develop 
normally up to 7 to 10 days after birth. At this stage the outer 
segment of the rod cell has begun to form, and in wild type 
mice it elongates rapidly during the 10th to 15th days. In 
Pde6brd1/Pde6brd1 mice the nascent outer segments and the rod 
cells degenerate rapidly so that by 15 days there is only a thin 
layer of rod cells left, and they have disappeared completely 
by 35 days (J:5250, J:5708). The inner nuclear layer and the 
retinal ganglion cells appear normal butmay show slight 
quantitative reduction (J:5812, J:5292). 
Although the eyes of Pde6brd1 homozygotes are devoid of 
normal rods, the mice have some visual capacity (J:5980). 
About 3% of cones among the visual cells degenerate at a 
much slower rate than do rods, so that a few cones are still 
present at 18 months (J:5988). The surviving cones are 
postulated (J:25157) as the light receptors required for the 
persistence of circadian responses to dawn and dusk in 
Pde6brd1 homozygotes past the sstage when rods have 
disappeared (J:29236). 
In fusion chimeras between wild type and Pde6brd1 
homozygous embryos, the Pde6brd1 mutant acts in the 
photoreceptor cells rather than in the pigment epithelium of 
the retina (J:5708). Action within photoreceptor cells is also 
implied by the long term survival of wild type rod cells 
transplanted into Pde6brd1 homozygote retinas (J:20769). At a 
stage before degeneration can be seen, a deficiency of cGMP-
PDE, andan excess of cGMP, appears in rod photoreceptor 
cells (J:5332). 
The rate of retinal degeneration in mutants doubly 
homozygous for two retinal degeneration mutations (Pde6brd1 
and RdsRd2) is intermediate between those of the two 
homozygotes (J:12044). The double homozygote shows an 
intermediate level of mRNAs for the ß subunit of cGMP-PDE 
and for several other phototransduction related proteins, 
suggesting an interaction between Pde6brd1 and RdsRd2 
(J:2579).  
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Genbank ID for mutant sequence: M75166  
Molecular Note Two mutations have been identified in rd1 mice. A murine 
leukimia virus (Xmv-28) insertion in reverse orientation in 
intron 1 is found in all mouse strains with the rd1 phenotype. 
Further, a nonsense mutation (C to A transversion) in codon 
347 that results in a truncation eliminating more than half of 
the predicted encoded protein, including the catalytic domain 
has also been identified in all rd1 strains of mice. A specific 
degradation of mutant transcript during or after pre-mRNA 
splicing is suggested. 
 
 
Colony Maintenance 
Diet Information LabDiet® 5K52/5K67
 
Phenotypic Data 
Mouse Phenome Database  
Festing Inbred Strain Characteristics: C3HeB  
 
Additional Web Information 
C3H strains free of exogenous MMTV  
Genetic Quality Control Annual Report  
JAX Notes, April 1988; 433. H-2 Haplotypes of Mice from Jackson Laboratory 
Production Colonies.  
JAX Notes, July 1987; 430. LPS Responsiveness of C3H Substrains.  
JAX Notes, May 2000; 480. C3H Strains Free of Exogenous MMTV.  
JAX Notes, Spring 2002; 485. Genetic Background Effects: Can Your Mice See?  
 
Animal Health Reports 
Room Number           MP14  
 
Research Applications 
This mouse can be used to support research in many areas including:  
Research Tools:  General Purpose  
Sensorineural Research 
Retinal Degeneration (Homozygous for Pde6brd1)  
Pde6brd1 related  
Mouse/Human Gene Homologs 
retinitis pigmentosa, autosomal recessive  
Appendix B: Information on the mutant mouse strain (C3H/HeJ) 
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From:  http://jaxmice.jax.org/strain/000659.html 
 
JAX Mice Datasheet 
Strain Name:  C3H/HeJ 
Stock Number:  000659 
 
Product Information 
 
Strain Details 
Type Inbred Strain 
 Additional information on Inbred Strains. 
Type JAX® GEMM® Strain - Spontaneous Mutation 
 Additional information on JAX® GEMM® Strains. 
TJL Mating System Sibling x Sibling         (Female x Male) 
  
Species laboratory mouse 
H2 Haplotype k 
Generation F260 (14-DEC-06)  
Appearance 
agouti 
Related Genotype: A/A  
Important Note 
This strain does not carry mouse mammary tumor virus (MMTV). See JAX Notes, May 
2000, #480. This strain is homozygous for retinal degeneration allele Pde6brd1, the 
defective lipopolysaccharide response allele Tlr4Lps-d, and for a chromosomal inversion 
on Chromosome 6.  
Strain Description 
C3H/HeJ mice are used as a general purpose strain in a wide variety of research areas 
including cancer, immunology and inflammation, sensorineural, and cardiovascular 
biology research. C3H/HeJ mice and all other Jackson substrains are homozygous for the 
retinal degeneration 1 mutation (Pde6brd1), which causes blindness by weaning age. 
There is also a high incidence of hepatomas in C3H mice (reportedly 72-91% in males at 
14 months, 59% in virgin females, 30-38% in breeding females). Despite the lack of 
exogenous mouse mammary tumor virus (MMTV), virgin and breeding females may still 
develop some mammary tumors later in life. C3H/HeJ mice, fed an atherogenic diet 
(1.25% cholesterol, 0.5% cholic acid and 15% fat), fail to develop atherosclerotic aortic 
lesions in contrast to several highly susceptible strains of mice (e.g. C57BL/6J, Stock No. 
000664; C57L/J, Stock No. 000668, C57BR/cdJ, Stock No. 000667, and SM/J, Stock No. 
000687).  
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C3H/HeJ mice spontaneously develop alopecia areata (AA) at a reported incidence of 
approximately 0.25% by 18 months of age. Alopecia areata has been demonstrated to be 
surgically-induced by grafting a small piece of skin from an older, donor animal with AA 
onto a younger, isogenic C3H/HeJ recipient. Visit the JAX® Surgical Model for 
Alopecia Areata Web page for more information on this surgically induced model.  
A spontaneous mutation occurred in C3H/HeJ at lipopolysaccharide response locus 
(mutation in toll-like receptor 4 gene, Tlr4Lps-d) making C3H/HeJ mice endotoxin 
resistant. C3H/HeJ (Tlr4Lps-d) mice are highly susceptible to infection by Gram-negative 
bacteria such as Salmonella enterica. Mice infected with Salmonella exhibit delayed 
chemokine production, impaired nitric oxide generation and attenuated cellular immune 
responses. Mortality in infected mice appears to be the result of enhanced bacterial 
growth within the liver Kupffer cell network (Vazquez-Torres et al., 2004).  
The C3H/HeJ substrain is homozygous for an inversion on Chromosome 6 named 
In(6)1J. The inversion covers 20% of Chromosome 6 between D6Mit124 (~30.3 cM) and 
D6Mit150 (~51.0 cM). The inversion has no apparent effect on phenotype. Results from 
screening other C3H substrains and cryopreserved stock from C3H/HeJ suggest that the 
mutation arose after 1952. See JAX Notes, Fall 2003, No. 491.  
Strain Development 
The C3H parent strain was developed by LC Strong in 1920 from a cross of a Bagg 
albino female with a DBA male followed by selection for high incidence of mammary 
tumors. This high incidence resulted from exogenous mouse mammary tumor virus 
(MMTV) transmitted through the mother's milk. The Jackson Laboratory maintains four 
C3H substrains, C3H/HeJ (Stock No. 000659), C3H/HeOuJ (Stock No. 000635), 
C3HeB/FeJ (Stock No. 000658) and C3H/HeSnJ (Stock No. 000661) that are now free of 
exogenous MMTV. C3H/HeJ and C3H/HeOuJ mice previously carried MMTV but were 
rederived in 1999 during planned efforts to increase the overall health status of the mice 
and the virus was not reintroduced. C3H/HeJ and C3H/HeOuJ substrains were separated 
in 1952 and are genetically very similar. However, a spontaneous mutation occurred in 
C3H/HeJ sometime between 1960 and 1968 at lipopolysaccharide response locus 
(mutation in toll-like receptor 4 gene, Tlr4lps) making C3H/HeJ mice endotoxin resistant 
while the other three C3H strains are endotoxin sensitive.  
Gene & Allele Details 
Allele Symbol In(6)1J 
Allele Name inversion, Chr 6, Jackson 1 
Strain of Origin C3H/HeJ 
General Note C3H/HeJ and C3H/HeJBir carry this inversion; C3H/HeSnJ 
and C3HeB/FeJ do not. Examination of recombination 
distances in Recombinant Inbred (RI) strain sets developed 
using C3H/HeJ as a progenitor suggest none of these harbor 
the inversion. Mouse strains carrying spontaneous mutations 
that arose on the C3H/HeJ background after 1965-1970 could 
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carry the inversion and are expected to if the mutation arose 
after the early 1970s. 
Molecular Note The In(6)1J inversion covers approximately 20% of Chr 6 in 
C3H/HeJ mice. Therefore, linkage crosses using C3H/HeJ 
will show no recombination in this region of Chr 6. Genetic 
analyses of congenic construction crosses suggested that the 
suppressed region lies between D6Mit124 (cytological band 
6C3) and D6Mit150 (cytological band 6F1). FISH analyses 
using flanking BACs detected a paracentric chromosomal 
region between ~73 Mb and ~116 Mb. 
     
Allele Symbol Pde6brd1 
Allele Name retinal degeneration 1 
Common Name(s) rd; rd-1; rodless retina;  
Gene Symbol and Name Pde6b, phosphodiesterase 6B, cGMP, rod receptor, beta 
polypeptide 
Chromosome 5 
Gene Common Name(s) CSNB3; PDEB; Pdeb; nmf137; phosphodiesterase, cGMP, 
rod receptor, beta polypeptide; r; rd; rd-1; rd1; rd10; retinal 
degeneration; retinal degeneration 1; retinal degeneration 10;  
General Note Pde6brd1, retinal degeneration 1, recessive. Formerly r, rd, rd1. 
A mutation causing retinal degeneration described by 
Bruckner (J:25576) and by Tansley (J:15333) in various 
stocks was later found to be present in many inbred strains 
(J:114). Keeler (J:5007) thought it to be identical with the 
rodless retina mutation he had described in 1924 (J:24999); 
the identity has recently been proven by analyses of DNA 
from Keeler's original slides (J:15231).  
Homozygotes are fully viable and fertile.Eyes develop 
normally up to 7 to 10 days after birth. At this stage the outer 
segment of the rod cell has begun to form, and in wild type 
mice it elongates rapidly during the 10th to 15th days. In 
Pde6brd1/Pde6brd1 mice the nascent outer segments and the rod 
cells degenerate rapidly so that by 15 days there is only a thin 
layer of rod cells left, and they have disappeared completely 
by 35 days (J:5250, J:5708). The inner nuclear layer and the 
retinal ganglion cells appear normal butmay show slight 
quantitative reduction (J:5812, J:5292). 
Although the eyes of Pde6brd1 homozygotes are devoid of 
normal rods, the mice have some visual capacity (J:5980). 
About 3% of cones among the visual cells degenerate at a 
much slower rate than do rods, so that a few cones are still 
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present at 18 months (J:5988). The surviving cones are 
postulated (J:25157) as the light receptors required for the 
persistence of circadian responses to dawn and dusk in 
Pde6brd1 homozygotes past the sstage when rods have 
disappeared (J:29236). 
In fusion chimeras between wild type and Pde6brd1 
homozygous embryos, the Pde6brd1 mutant acts in the 
photoreceptor cells rather than in the pigment epithelium of 
the retina (J:5708). Action within photoreceptor cells is also 
implied by the long term survival of wild type rod cells 
transplanted into Pde6brd1 homozygote retinas (J:20769). At a 
stage before degeneration can be seen, a deficiency of cGMP-
PDE, andan excess of cGMP, appears in rod photoreceptor 
cells (J:5332). 
The rate of retinal degeneration in mutants doubly 
homozygous for two retinal degeneration mutations (Pde6brd1 
and RdsRd2) is intermediate between those of the two 
homozygotes (J:12044). The double homozygote shows an 
intermediate level of mRNAs for the ß subunit of cGMP-PDE 
and for several other phototransduction related proteins, 
suggesting an interaction between Pde6brd1 and RdsRd2 
(J:2579).  
Genbank ID for mutant sequence: M75166  
Molecular Note Two mutations have been identified in rd1 mice. A murine 
leukimia virus (Xmv-28) insertion in reverse orientation in 
intron 1 is found in all mouse strains with the rd1 phenotype. 
Further, a nonsense mutation (C to A transversion) in codon 
347 that results in a truncation eliminating more than half of 
the predicted encoded protein, including the catalytic domain 
has also been identified in all rd1 strains of mice. A specific 
degradation of mutant transcript during or after pre-mRNA 
splicing is suggested. 
     
Allele Symbol Tlr4Lps-d 
Allele Name defective lipopolysaccharide response 
Common Name(s) Tlr4-; lpsd;  
Strain of Origin C3H/HeJ 
Gene Symbol and Name Tlr4, toll-like receptor 4 
Chromosome 4 
Gene Common Name(s) CD284; Lps; RAS-like, family 2, locus 8; Rasl2-8; TOLL; 
hToll; lipopolysaccharide response;  
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General Note C3H/HeJ mice carry this allele. Various combinations of Lps-
associated traits have been followed in crosses between 
C3H/HeJ and other C3H substrains, and the traits have in all 
cases segregated together (J:30692, J:5557, J:5593, J:5938). 
Some of the traits show dominance of the Tlr4Lps-n allele; 
others, including Tlr4Lps-d, show codominance. 
Molecular Note This allele corresponds to a mutation in the third exon of the 
gene. The substitution of an A to C at nucleotide position 
2342, results in an amino acid substitution that replaces 
proline with histidine at position 712.  
 
Colony Maintenance 
Diet Information LabDiet® 5K52/5K67
 
Phenotypic Data 
UPDATED Body Weight Information - JAX® Mice Strain C3H/HeJ (000659)  
(This chart reflects the typical correlation between body weight and age for mice 
maintained in production colonies at The Jackson Laboratory.) 
 
Mouse Phenome Database  
Mouse Phenome Database - body weight  
Mouse Phenome Database - cardiovascular  
Mouse Phenome Database - disease susceptibility  
Mouse Phenome Database - ethanol effects  
Mouse Phenome Database - food and water intake  
Mouse Phenome Database - hematology  
Mouse Phenome Database - lungs  
Mouse Phenome Database / SNP Facility  
Festing Inbred Strain Characteristics: C3H  
 
Additional Web Information 
A Surgically Induced Model of Alopecia Areata.  
C3H strains free of exogenous MMTV  
Genetic Quality Control Annual Report  
JAX Notes, April 1988; 433. H-2 Haplotypes of Mice from Jackson Laboratory 
Production Colonies.  
JAX Notes, Fall 2003; 491. Chromosomal Inversion Discovered in C3H/HeJ Mice  
JAX Notes, January 1988; 432. Arthritis Models in the Mouse.  
JAX Notes, July 1987; 430. LPS Responsiveness of C3H Substrains.  
JAX Notes, July 1987; 430. Mammary Tumor Incidence in C3H/HeJ and C3H/OuJ.  
JAX Notes, Spring 1995; 461. Neoplastic and Hyperplastic Lesions in the C3H/HeJ 
Mouse Strain.  
JAX Notes, Spring 2003; 489. Malocclusion in the Laboratory Mouse.  
JAX Notes, Spring 2005; 497. Update of Chromosome 6 Inversion in JAX&#-82; Mice 
Strain C3H/HeJ.  
JAX Notes, Summer 2003; 490. Hydrocephalus in Laboratory Mice.  
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JAX Notes, Summer 2005; 498. Toll-like Receptor JAX&#-82; Mice for Immunological 
Research.  
JAX Notes, Winter 2006; 504. JAX® Mice: the Gold Standard Just Got Better.  
JAX Notes, Winter 2006; 504. Reliable New Sperm Cryopreservation Service Developed 
at The Jackson Laboratory.  
 
Animal Health Reports 
Room Number           AX10  
Room Number           MP13  
 
Research Applications 
This mouse can be used to support research in many areas including:  
Cancer Research 
Increased Tumor Incidence (Hepatomas)  
Increased Tumor Incidence (Mammary Gland Tumors: late onset)  
Cardiovascular Research 
Diet-Induced Atherosclerosis (Relatively Resistant)  
Immunology and Inflammation Research 
Immunodeficiency (Tlr deficiency)  
Research Tools 
General Purpose  
Sensorineural Research 
Retinal Degeneration (Homozygous for Pde6brd1)  
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Appendix C:  Endotoxin Analysis Protocol (VIDO)  
 
 
Endotoxin Assay Protocol/LAL (Limulus Amebocyte Lysate) Test 
Updated April 27/04 JG 
 
Materials: 
♦ QCL-1000 LAL Assay Kit (Cambrex, #50-648U) 
♦ Sterile injectable water (DIN 00624721; Astra Pharm Inc.; Mississauga, ON, Canada) 
Store at room temperature (RT) 
♦ Stop reagent (10% w/v SDS) 
♦ 5-mL polypropylene tubes (Falcon #2063; VWR) 
♦ Disposable, pyrogen-free microplates (Falcon #3072; VWR) 
♦ Multi-block heater, Vortex mixer 
♦ Timer/microplate reader/Test tube rack/Gloves 
♦ 200µL and 1000µL pipettors 
 
Procedure: 
1. General: 
1. wear gloves 
2. change pipette tips for each sample 
3. test standards and blank duplicate 
2. Reconstitute Reagents: 
**Store at 4oC & use within 1 week** 
E. Coli (0111:B4) Endotoxin 
i. Add 1.0 mL sterile injectable water (room temperature) to the vial. 
ii. Vortex 15 minutes and keep at RT until use. 
 
Chromogenic Substrate: Add 6.5mL sterile injectable water with volumetric pipet. 
 
Limulus Amebocyte Lysate (LAL) 
i. Add 3.0mL sterile injectable water with polypropylene volumetric pipet. 
ii. Gently swirl the solution to avoid foaming. 
iii. Pool contents of vials if more than one vial is required. 
 
3. Prepare Standards: 
Four standards will be prepared: 1.0, 0.5, 0.25, 0.1EU/mL. 
The initial dilution from the stock solution will be 1/X, where X = the concentration of 
the endotoxin vial. This will yield a 1.0 EU/mL solution. i.e. If the potency of the 
endotoxin vial is 25 EU/mL, the initial dilution will be 1/25 or 0.1mL of stock solution in 
2.4mL sterile injectable water. 
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Table 1. A summary of how the four standards are to be prepared. 
 Standard 1 1.0EU/mL 
Standard 2 
0.5EU/mL 
Standard 3 
0.25EU/mL 
Standard 4 
0.1EU/mL 
Standard 5 
0.0EU/mL 
Sterile 
Water (x-1)/10* 0.5mL 1.5mL 0.9mL 1.0mL 
Stock 
Solution 0.1mL 0 0 0 0 
Standard 1 
Solution 0 0.5mL 0.5mL 0.1mL 0 
*x = concentration of stock solution as indicated in the certificate 
 
Standard 1 solution must be vortexed for 2 minutes before standards 2-4 can be prepared. 
In addition, standards 1-4, blank and all samples are to be vortexed for 2 minutes prior to 
analysis 
 
4. Sample Preparation: 
All samples will be analyzed in a dilution series (10-0, 10-1, 10-2, 10-3) to ensure accurate 
readings on those samples that have concentrations that do not fit the standard curve.  
 
Each dilution series should be vortexed for 2 minutes before the preparation of the next 
solution in the series. 
 
5. Test Procedure: 
i. Set multi-block heater at 37oC and pre-heat microplate for 5 minutes or longer. 
ii. While microplate is on the block heater dispense 50µL of samples, blank (sterile 
injectable water) and standards into appropriate wells. Remember to change pipette 
tip after every well. 
iii. At T=0 add 50µL of LAL to all the wells. Begin timer when the LAL is added to the 
first well. Maintain a constant rate of pipetting. Once LAL has been added to all the 
wells remove the microplate from the block heater and gently tap the side of the plate 
20 times in order to mix contents. Return microplate to heater after mixing. 
iv. At T=10 minutes add 100µL of the chromogenic substrate to all wells. Substrate must 
be warmed to 37oC by putting in an incubator for 10 minutes or longer. Again, 
remove microplate and gently tap side of plate 20 times, returning it to the heat after 
mixing is complete. 
v. At T=16 minutes add 50µL stop solution (10% SDS) to all wells. Remove microplate 
from heat and mix by gently tapping side of plate 20 times.  
vi. Read the absorbance at 405nm. Use a reference wavelength of 490nm. Plate should 
be read twice and an average of the readings used to calculate the concentrations. 
 
Calculation of Endotoxin Concentration:  
Plot the mean change in absorbance (absorbance minus background absorbance) for the 5 
standards on the y-axis versus the corresponding endotoxin concentration in EU/mL on 
the x-axis. Draw a best-fit line between these points and determine the concentrations of 
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the samples graphically. In order to calculate the mean change in absorbance the mean 
absorbance of the blank must be subtracted from the standards and the samples. All of 
these calculations can be done in Microsoft Excel. Once the concentrations of the 
samples are determined, they must be multiplied by their dilution factors in order to 
obtain the actual concentration and those concentrations averaged for the final value. The 
geometric mean of the dilution series for each sample is calculated. The final 
concentration is expressed in EU/mL, whereas most of the literature expresses endotoxin 
concentrations in EU/m3. Therefore, the following conversion factor is used:  
 
EU x 10 min x  L   x     m3 
mL     x           min    1000-L 
 
 
Reference: 
BioWhittaker, Inc. Limulus Amebocyte Lysate QCL-1000 Test Kit Manual. Cat. No. 
50-648-U.  
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Appendix D:  Antibodies used for Immunohistochemistry 
 
Primary  
 Antibodies Concentration Dilution Manufacturer Product Code
 Secondary     
 Antibody Concentration Dilution Manufacturer Product Code 
 TLR4 200 ug/mL  1:50 Santa Cruz  12511  rabbit anti-goat     IgG 800 ug/mL  1:200 
Dako 
Cytomation E0466 
 TLR4 Blocking 
 Peptide 200 ug/mL  1:50  Santa Cruz 12511 P  
 rabbit anti-goat   
 IgG 800 ug/mL  1:200 
Dako 
Cytomation E0466 
 vWF  3.1 g/L  1:300 Dako Cytomation A0082 
 goat anti-rabbit    
 IgG 300 ug/mL  1:75 
Dako 
Cytomation  P0448  
 CD34 200 ug/mL  1:50 Santa Cruz  7045  rabbit anti-goat   IgG 800 ug/mL  1:200 
Dako 
Cytomation E0466 
 VEGF-A 200 ug/mL  1:50 Santa Cruz  152  goat anti-rabbit     IgG 300 ug/mL  1:75 
Dako 
Cytomation  P0448  
 VEGFR-1  
 (Flt-1) 200 ug/mL  1:50 Santa Cruz  316 
 goat anti-rabbit    
 IgG 300 ug/mL  1:75 
Dako 
Cytomation  P0448  
 VEGFR-2  
 (Flk-1) 200 ug/mL  1:50 Santa Cruz  505 
 goat anti-rabbit    
 IgG 300 ug/mL  1:75 
Dako 
Cytomation  P0448  
 Rabbit IgG 200 ug/mL  1:50 Santa Cruz  2027   goat anti-rabbit     IgG 300 ug/mL  1:75 
Dako 
Cytomation  P0448  
 Goat IgG 500 ug/mL  1:125 Santa Cruz  2028  rabbit anti-goat   IgG 800 ug/mL  1:200 
Dako 
Cytomation E0466 
 1% BSA  -   -   -   -   anti- goat/rabbit   IgG  -   -   -   -  
          
 Concentration Dilution Manufacturer Product Code      
Streptavidin 620 ug/mL  1:155 Dako Cytomation P0397      
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Appendix E:  ELISA Protocol 
 
Sample Preparation – Tissue 
 
1. Get sample (frozen or fresh), and put in liquid nitrogen 
2. Prepare 1X HBSS mixture 
a. 1 mL 10X HBSS: 9 mL dH2O 
3. Weigh out tissue 
4. Dilute tissue in HBSS mix 
a. 100 mg tissue per mL HBSS mix 
5. Homogenize 
6. Keep samples on ice 
7. Centrifuge to remove particulates once samples are prepared 
a. 25 000 Rcf 
b. 4 degrees C 
c. 15 min 
8. Aliquot ~100 uL sample per microcentrifuge tube 
9. Store at –80 degrees C until used 
 
Sample Preparation – BAL 
 
None required, except possibly dilution 
 
 
ELISA method for VEGF-A Assay: 
 
Purchased Quantikine ELISA kit (Catalogue Number MMV00).  Methods outlined in kit 
instructions. 
 
Bring all reagents to room temperature before use. 
 
Reagent preparation for VEGF-A assay: 
1) Reconstitute VEGF Kit Control with 1.0 mL deionized water 
a. Assay the control undiluted. 
2) Add 25 mL wash buffer concentrate to dH2O to prepare 625 mL Wash Buffer 
3) Colour reagents A &B should be mixed together in equal volumes within 15 min 
of use.  Add 100 uL per well. 
4) Reconstitute the VEGF standard with 5.0 mL of calibrator diluent RD5T.  
Produces stock solution of 500 pg/mL.  Allow standard to sit for 5 min with 
gentle mixing prior to making dilutions. 
5) Pipette 20 uL Calibrator diluent RD5T into each polyprolylene tube.  Use the 
stock solution to produce a 2-fold dilution series.  
 
Supplies required: 
• Microplate reader capable of measuring 450 nm, with the correction wavelength 
set at 540 nm or 570 nm. 
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• Multi-channel pipette, squirt bottle, manifold dispenser, or automated microplate 
washer 
• 1000 mL graduated cylinder 
• POLYPROPYLENE test tubes 
 
Assay procedure for VEGF kit: 
1) Prepare all reagents, working standards, and samples as directed in the previous 
sections. 
2) Remove excess microplate strips from the plate frame, return them to the foil 
pouch containing the dessicant pack and reseal. 
3) Add 50 uL of Assay Diluent RD1N to each well 
4) Add 50 uL of standard, control or sample to each well.  Mix by gently tapping the 
plate frame for 1 minute.  Cover with adhesive strip.  Incubate for 2 hours at room 
temperature.   
5) Aspirate each well and wash, repeating the process 4 times for a total of 5 washes.  
Wash by filling each well with wash buffer (400 uL).  Complete removal of liquid 
at each step is essential.   After the last wash, remove any remaining wash buffer 
by aspirating or decanting.  Invert the plate and blot it against clean paper towels. 
6) Add 100 uL of mouse VEGF conjugate to each well.  Cover with a new adhesive 
strip.  Incubate for 2 hours at room temperature. 
7) Repeat as in step 5 
8) Add 100 uL of substrate solution to each well.  Incubate for 30 min at room 
temperature.  Protect from light! 
9) Add 100 uL of stop solution to each well.  Gently tap the plate to ensure thorough 
mixing. 
10) Determine the optical density of each well within 30 min using a microplate 
reader set to 450 nm.  Set wavelength correction to 540 nm or 570 nm.  If 
wavelength correction is not available, subtract readings at 540 nm or 570 nm 
from the 450 nm reading to correct for optical imperfections in the plate. 
 
 
Notes:   
For best results, pipette reagents and samples into the centre of each well. 
Complete all pipetting within 15 minutes 
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ELISA method for sVEGR-1 Assay: 
 
Purchased Quantikine ELISA kit (Catalogue Number MVR100).  Methods outlined in kit 
instructions. 
 
Bring all reagents to room temperature before use. 
 
Reagent preparation for sVEGFR-1 assay: 
1) Reconstitute sVEGFR-1 Kit Control with 1.0 mL deionized water 
a. Assay the control undiluted. 
2) Add 25 mL wash buffer concentrate to dH2O to prepare 625 mL Wash Buffer 
3) Colour reagents A &B should be mixed together in equal volumes within 15 min 
of use.  Add 100 uL per well. 
4) Reconstitute the VEGFR-1 standard with 2.0 mL of calibrator diluent RD5-3.  
Produces stock solution of 8000 pg/mL.  Allow standard to sit for 5 min with 
gentle mixing prior to making dilutions. 
5) Pipette 20 uL Calibrator diluent RD5-3 into each polyprolylene tube.  Use the 
stock solution to produce a 2-fold dilution series.  
 
Supplies required: 
• Microplate reader capable of measuring 450 nm, with the correction wavelength 
set at 540 nm or 570 nm. 
• Multi-channel pipette, squirt bottle, manifold dispenser, or automated microplate 
washer 
• 1000 mL graduated cylinder 
• POLYPROPYLENE test tubes 
 
Assay procedure for VEGFR-1 kit: 
1) Prepare all reagents, working standards, and samples as directed in the previous 
sections. 
2) Remove excess microplate strips from the plate frame, return them to the foil 
pouch containing the dessicant pack and reseal. 
3) Add 50 uL of Assay Diluent RD1-21 to each well 
4) Add 50 uL of standard, control or sample to each well.  Mix by gently tapping the 
plate frame for 1 minute.  Cover with adhesive strip.  Incubate for 2 hours at room 
temperature.   
5) Aspirate each well and wash, repeating the process 4 times for a total of 5 washes.  
Wash by filling each well with wash buffer (400 uL).  Complete removal of liquid 
at each step is essential.   After the last wash, remove any remaining wash buffer 
by aspirating or decanting.  Invert the plate and blot it against clean paper towels. 
6) Add 100 uL of mouse VEGFR-1 conjugate to each well.  Cover with a new 
adhesive strip.  Incubate for 2 hours at room temperature. 
7) Repeat as in step 5. 
8) Add 100 uL of substrate solution to each well.  Incubate for 30 min at room 
temperature.  Protect from light! 
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9) Add 100 uL of stop solution to each well.  Gently tap the plate to ensure thorough 
mixing. 
10) Determine the optical density of each well within 30 min using a microplate 
reader set to 450 nm.  Set wavelength correction to 540 nm or 570 nm.  If 
wavelength correction is not available, subtract readings at 540 nm or 570 nm 
from the 450 nm reading to correct for optical imperfections in the plate. 
 
 
Notes:   
For best results, pipette reagents and samples into the centre of each well. 
Complete all pipetting within 15 minutes 
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Appendix F :  RNA extraction with TRIZOL reagent 
 
FIRST PURIFICATION:  
RNA Extraction with TRIZOL Reagent 
 
1) Homogenize 50-100 mg tissue in liquid nitrogen, and transfer homogenate 
into 1 mL TRIZOL reagent.  
2) Incubate for 5 min at room temperature. 
3) Add 200 :L CHCl3 (chloroform), shake tubes vigorously by hand for 15 
seconds and incubate at room temperature for 2 minutes. 
4) Centrifuge at 10 000 rpm for 10 minutes at 4 °C. 
5) Transfer aqueous (top) phase to fresh tube and add 500 :L ispropoanol 
(pre-chilled), incubate at room temperature for 15 minutes. 
6) Centrifuge at 14 000 rpm for 20 min at 4 °C.  
i. this will precipitate RNA – TURN CAP FLIP TO INSIDE OF 
CENTRIFUGE SO PELLET WILL FORM ON BOTTOM OF 
OUTSIDE OF TUBE 
7) Wash RNA pellet once with 200 µL 100% ethanol.  Close the caps, vortex for 
<2 seconds and centrifuge at 12 000 rpm for 10 min at 4 °C. 
8) Allow RNA pellet to dry (looks translucent) after draining ethanol.  Do not 
dislodge the pellet when draining the ethanol. 
9) Re-distribute the pellet in 50 µL RNAse-free water:  
i. Dissolve by tapping. 
ii. Store at –20 °C, or follow the purification steps immediately. 
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SECOND PURIFICATION:  RNA Clean-up 
 
1. Adjust sample volume to 100 :L with RNAse-free water. 
2. Add 350 :L RLT buffer and mix (ensure beta-mercaptoethanol is 
added to RLT before mixing!) 
3. Add 250 :L 100% ethanol. 
4. Mix thoroughly by pipetting. 
5. Apply 700 :L sample to RNeasy mini-column placed in 2 mL 
collecting tube. 
6. Centrifuge for 30 seconds at 14 000 rpm and discard flow-through. 
7. Add 350 :L RW1. 
8. Centrifuge at 14 000 rpm for 30 seconds and discard flow-through. 
9. Centrifuge empty column at 14 000 rpm for 30 seconds to dry 
membrane. 
10. Make solution:  
i. 10 :L DNAse I + 70 :L RDD for EACH sample  
ii. Add 80 :L mix to each filter 
iii. Let sit for 15 min at room temperature  
11. Add 350 :L RW1. 
12. Centrifuge for 30 seconds at 14 000 rpm. 
13. Add 500 :L RPE 
14. Centrifuge for 30 seconds at 14 000 rpm. 
15. Add 500 :L RPE 
16. Centrifuge 2 min at 8 000 rcf. 
17. Add 60 :L RNAse-free water, wait 2 minutes at room temperature. 
18. Put filter into microcentrifuge tube. 
19. Centrifuge for 2 minutes at 14000 rpm to collect RNA in collecting 
tube.  
20. Store at –20 °C. 
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Appendix G:  Primers used for quantitative RT-PCR 
 
Desalted Primers used for Quantitative Real-time Reverse-transcriptase Polymerase 
Chain Reaction (qPCR) 
 
 
Mouse VEGF-A 
 
Forward primer   ATG  AAC  TTT  CTG  CTC  TCT  TGG 
Reverse primer    TGC  ACA  GCG  CAT  CAG  CGG  CAC 
 
Mouse VEGFR-1 
 
Forward primer   GGC AGA CCA ATA CAA TCC TAG ATG 
Reverse primer    ACC AGG GTA ATT CCA GCT CAT TT 
 
Mouse VEGFR-2 
 
Forward primer   ATG TGC  TGT CTT  TAG  AAG 
Reverse primer    AGA  CAT  CTC  TCT  ACA  GCT 
 
